PRECISION OPTICS CORPORATION INC
10KSB, 1996-09-19
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: DESTEC ENERGY INC, S-3/A, 1996-09-19
Next: TANDY BRANDS ACCESSORIES INC, DEF 14A, 1996-09-19



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-KSB

                ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

                     For the Fiscal Year Ended June 30, 1996

                        Commission File Number 001-10647

                       PRECISION OPTICS CORPORATION, INC.
                 (Name of small business issuer in its charter)

              MASSACHUSETTS                             04-279-5294
      (State or other jurisdiction                   (I.R.S. Employer
    of incorporation or organization)               Identification No.)

                                22 EAST BROADWAY
                          GARDNER, MASSACHUSETTS 01440
               (Address of principal executive offices) (Zip Code)

                   Issuer's telephone number is (508) 630-1800

           Securities registered pursuant to Section 12(b) of the Act:

                                                    Name of each exchange on
   Title of each class                                   which registered

COMMON STOCK, $.01 PAR VALUE                       BOSTON STOCK EXCHANGE, INC.

Securities registered pursuant to Section 12(g) of the Act: None

         Check whether the issuer (1) filed all reports  required to be filed by
Section  13 or 15 of the  Exchange  Act  during  the past 12 months (or for such
shorter period that the  registrant was required to file such reports),  and (2)
has been subject to such filing requirements for the past 90 days. Yes X No

         Check if no disclosure of delinquent filers to Item 405 of Regulation
S-B is contained in this form, and no disclosure will be contained, to the best
of registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-KSB or any amendment to
this Form 10-KSB.   X

         The issuer's revenues for its most recent fiscal year were $8,055,271.

         The aggregate  market value of the voting stock,  consisting  solely of
common stock,  held by non-affiliates of the issuer computed by reference to the
closing price of such stock was $7,808,409 as of June 30, 1996.

         The number of shares of  outstanding  common  stock of the issuer as of
August 31, 1996 was 5,980,502.


                       DOCUMENTS INCORPORATED BY REFERENCE

         The  issuer's   Proxy   Statement  for  the  1996  Annual   Meeting  of
Shareholders  to be held on November 12, 1996 is  incorporated  into Part III of
this Form 10-KSB.

                                  Page 1 of 31
3145003.02

<PAGE>



                                     PART I

ITEM 1.   BUSINESS

Business Development.

         Precision Optics Corporation, Inc. (the "Company") designs, develops,
manufactures, and sells specialized optical systems and components and optical
thin film coatings.

         The Company completed a private placement of 1,000,000 shares of Common
Stock in August 1990, an initial public  offering of 1,200,000  shares of Common
Stock in November  1990,  and a public  offering of  1,176,250  shares of Common
Stock in February 1992. In conjunction with these offerings,  the Company issued
warrants for a total of 320,000  shares of Common Stock to the selling agent and
underwriters  for  the  offerings.  Before  these  offerings,  the  Company  was
privately  held.   Precision  Optics  Corporation,   Inc.  was  incorporated  in
Massachusetts in 1982.

         In August 1992, the Company  established a  wholly-owned  subsidiary in
Hong Kong to market and sell the Company's  products  throughout the Pacific Rim
marketplace  and to engage  in  general  activities  relating  to the  Company's
business.   Also  in  August  1992,  the  Company   established  a  wholly-owned
subsidiary,  Precise  Medical,  Inc.  ("Precise  Medical"),  to market  and sell
medical  video  endoscopy  systems  that  incorporated  the  Company's  products
directly to end users  (hospitals,  physicians,  etc.).  On July 14,  1993,  the
Company closed Precise Medical because of its inability to achieve acceptance in
the medical video systems marketplace.

         References to the Company contained herein include its two wholly-owned
subsidiaries except where the context otherwise requires.

Business of Issuer.

         The Company  designs,  develops,  manufactures,  and sells  specialized
optical  systems and  components  and optical  thin film  coatings.  The Company
conducts  business in one industry  segment  only.  The  Company's  products and
services fall into the following  areas:  medical  products for use by hospitals
and physicians,  industrial  optical  products and services and advanced optical
system design and  development  services and products,  primarily under contract
either  directly  or  indirectly  with  the  United  States   Government   ("the
Government").

         PRINCIPAL PRODUCTS AND SERVICES AND METHODS OF DISTRIBUTION

         Medical Products.  The Company's medical products are endoscopes and 
image couplers, beamsplitters, and adapters, which are used as accessories to
endoscopes.

         In January  1991,  the  Company  began the design  and  development  of
endoscopes using various optical  technologies for use in a variety of minimally
invasive  surgical and  diagnostic  procedures  throughout  the human body.  The
Company's  endoscope sales have been primarily to manufacturers of video cameras
and medical  products and video endoscopy  systems.  In addition to its existing
line of  endoscopes,  the Company is  continuing to develop  different  types of
endoscopes that  incorporate  varying types of  construction  and technology for
varying medical specialties and functionality.

                                       -2-
3145003.02

<PAGE>



         The  Company  developed  and has  manufactured  and sold  since  1985 a
proprietary   product  line  of   state-of-the-art   instrumentation  to  couple
endoscopes to video cameras.  Included in this product line are image  couplers,
which  physically  connect the endoscope to the video camera system and transmit
the image viewed through the scope to the video camera.  Another  product -- the
beamsplitter  --performs  the same function  while  preserving for the viewer an
eyeport for direct,  simultaneous viewing through the endoscope. The Company has
sold these  devices  primarily to endoscope and video camera  manufacturers  and
suppliers for resale under its customers' names.

         The  Company's   image   couplers  and   beamsplitters   can  withstand
surgery-approved  sterilization.  The  Company  also offers  autoclavable  image
couplers,  which are able to withstand  sterilization in superheated steam under
pressure.  Autoclavability is a preferred method of sterilization because of its
relative speed,  safety,  and efficiency.  The Company believes there is a trend
toward increased  sterilization  of medical  instruments and that it is the only
company in the world that produces autoclavable image couplers.  The Company has
investigated   the  development  of  an  autoclavable   beamsplitter.   Although
autoclavable  endoscopes and video cameras,  the necessary components to a fully
autoclavable video-monitored endoscopy, are not yet available, the Company is in
the process of  developing  an  autoclavable  endoscope  and believes that video
camera manufacturers are attempting to develop autoclavable video cameras.

         There can be no assurance as to the general market acceptance of any of
the Company's new products.

         Included in the  Company's  medical  products  sales are sales of image
couplers  and  beamsplitters  for  video-monitored  examination  of a variety of
industrial cavities and interiors. The Company has developed, and may develop in
the future, specialized borescopes for industrial applications.

         Advanced Optical Design and Development Services.  The Company provides
on a contract basis advanced lens design, image analysis, optical system design,
structural  design and analysis,  prototype  production and  evaluation,  optics
testing,  and  optical  system  assembly.  Some  of  the  Company's  development
contracts have led to optical system  production  business for the Company,  and
the Company believes its prototype  development  service may lead to new product
production from time to time.

         Within the advanced optical design and development  area, the Company's
sales  recently have been largely of  night-vision  products and  services.  The
Company  designs,  manufactures,  and sells  night-vision  optical  systems  and
components that permit users to see in extreme low light.

         Under  contract  with a  customer  that  produces  and  sells  aviation
night-vision  goggles to the United  States  Army,  the Company has designed and
produced the eyepieces for aviators'  night-vision goggles.  Under contract with
the same  customer,  the Company  designed  and  currently  produces  collimator
assemblies for night-vision goggles used by ground personnel.

         Under  additional  design  and  development  contracts  with  the  same
customer,  the Company has designed an objective lens for aviators' night-vision
goggles, designed and built prototypes of an objective lens for ground personnel
goggles,  designed  and  built new lens  system  prototypes  for night  driver's
viewers and armament  sites,  and designed and built a magnifier  attachment for
ground

                                       -3-
3145003.02

<PAGE>



personnel goggles. In addition,  the Company has designed and currently produces
a new objective lens and eyepiece for aviators' night-vision goggles.

         The  Company  has  in the  past  and  expects  in the  future  to  have
difficulty competing for production  contracts for night-vision  products due to
the lower  prices  offered by foreign  manufacturers.  In  addition,  Government
budget uncertainties and efforts to lower the federal budget deficit and defense
spending may adversely affect the Company. The Company believes,  however,  that
some  of  its  night-vision   products  and  development  work  incorporate  new
technology which the Government may use to update its existing equipment.

         In addition to its  night-vision  related design and  development,  the
Company designs, develops, and manufactures thin film coatings and performs thin
film  coatings  for use on  various  optical  products.  Many  of the  Company's
advanced  optical  design and  development  projects and the  manufacture of the
Company's medical and night-vision  products have been  significantly  dependent
upon the Company's thin film capabilities. Presently, optical thin film business
not  associated  with other  Company  business  and  products is limited or very
specialized.

         The Company has also  developed a  lens-prism  system which it has sold
for industrial use as part of an automated  registration system for machines and
has developed and sells a lens system for optical character reading.

         COMPETITION AND MARKETS

         The areas in which the  Company  engages  are  highly  competitive  and
include both foreign and domestic competitors. Many of the Company's competitors
are  larger  and  have   substantially   greater  resources  than  the  Company.
Furthermore,  other domestic or foreign companies,  some with greater experience
in the optics  industry and greater  financial  resources than the Company,  may
seek to produce products or services that compete with those of the Company. The
Company  may  establish  or use  production  facilities  overseas to produce key
components to the Company's business,  such as lenses. The Company believes that
the cost savings from such production may be essential to the Company's  ability
to compete on a price basis in the medical and night-vision  optics areas and to
the Company's  profitability,  and that the Company's  inability to establish or
maintain such  production  facilities  could  materially,  adversely  affect the
Company.

         The Company  believes  that  competition  for sales of its products and
services,  which  have  been  principally  sold to OEM  customers,  is  based on
performance  and other  technical  features,  as well as other factors,  such as
scheduling and reliability, in addition to competitive price.

         The Company  currently  sells its image  couplers,  beamsplitters,  and
adapters to a market that consists of  approximately 30 potential OEM customers,
15 of which are in the  United  States.  These  potential  customers  sell video
cameras,  endoscopes,  or video-endoscopy systems. The Company has made sales to
approximately 10 of these customers,  most of which are camera suppliers and all
of  which  are  United  States  companies.  The  Company  estimates  that it has
approximately  30% of the market share in these products and anticipates  growth
in this area. The Company's  primary  competition in this area is the customers'
own in-house  capabilities to manufacture  such products.  The Company  believes
that these customers typically purchase products from the Company, despite their
in-house  capabilities,  because  they  choose  to devote  their  own  technical
resources to their primary

                                       -4-
3145003.02

<PAGE>



products,   such  as  cameras  or   endoscopes.   The  Company   estimates  that
approximately  50% of the market demand for image couplers,  beamsplitters,  and
adapters is met by "captive" or in-house  capabilities.  The Company anticipates
increased  demand for its  autoclavable  products because it believes there is a
trend towards more stringent sterilization of medical instruments.

         The Company has  marketed and sold its  endoscopes  to OEM video camera
and video endoscopy suppliers for resale under the purchaser's name. A number of
domestic and foreign competitors also sell endoscopes to such OEM suppliers, and
the Company's  share of the endoscope  market is nominal.  The Company  believes
that, while its resources are substantially more limited than these competitors,
the Company may be able to be more responsive to the needs of endoscope users.

         With respect to the Company's  advanced  optical design and development
services  not related to  night-vision  or thin film  coatings,  the Company has
numerous customers and competitors. The ability to supply design and development
services  to  such  customers  is  highly  dependent  upon a  company's  and its
employees' reputations and prior experience.

         With  respect  to  night-vision  optics,  the  Company's  sales  of its
products and services have been almost exclusively to one customer,  which sells
night-vision  equipment to the United  States Army.  The Company  faces  intense
competition for production of night-vision products from foreign  manufacturers.
In the night-vision  optical design area, the Company has numerous  competitors.
The Company's business in the night-vision  optics area is highly dependent upon
the Company's  reputation and performance,  as well as upon Government contracts
and policy.  The Company believes the demand for night-vision  optics generally,
which are used  extensively in drug and law enforcement and surveillance as well
as search and rescue  missions and military  applications,  will lessen.  Recent
experience  with lens sales for new consumer night vision products also suggests
that market growth in this area is severely limited.

         The Company's thin film coatings competitors are numerous and have deep
and broad capabilities.

         The Company has had negligible direct export sales to date.

         RESEARCH AND DEVELOPMENT

         The Company  believes that its future success depends to a large degree
on its ability to continue to conceive  and to develop new optical  products and
services  and  to  enhance  the  performance   characteristics  and  methods  of
manufacture of existing products. Accordingly, it expects to continue to seek to
obtain  product-related  design and development  contracts with customers and to
invest its own funds on its research and development.

         The Company  received  approximately  $1,060,000  and  $752,000 for the
fiscal  years ended June 30, 1996 and 1995,  respectively,  from  customers  for
customer-sponsored  design and development projects. Levels of customer contract
funded  research  and  development  can  fluctuate  greatly in any given  period
depending upon the mix between design efforts and hardware development, which is
generally more expensive and time consuming than the design phases.  In addition
to customer-sponsored research and development,  the Company spent approximately
$433,000  and  $363,000  of its own funds  during  fiscal  years  1996 and 1995,
respectively, on the Company's own research and

                                       -5-
3145003.02

<PAGE>



development.  The Company expects to continue making significant Company-funde
expenditures for research and development.

         RAW MATERIALS AND PRINCIPAL SUPPLIERS

         For all of the Company's products,  except for thin film coatings,  the
basic raw material is precision  grade optical glass,  which the Company obtains
from  several  major  suppliers.  Outside  vendors  grind and  polish all of the
Company's  lenses and prisms.  For  optical  thin film  coatings,  the basic raw
materials are metals and dielectric compounds,  which the Company obtains from a
variety of chemical  suppliers.  The Company  believes that its demand for these
raw  materials  and  services  is small  relative  to the total  supply and that
materials and services required for the production of its products are currently
available in sufficient  production  quantities and will be available for fiscal
year  1997.  The  Company  believes,  however,  that  there are  relatively  few
suppliers  of the high  quality  lenses  and  prisms  which its  endoscopes  may
require.  Depending upon the market acceptance of the Company's endoscopes,  the
Company may seek to assure itself of a timely supply of lenses, prisms, or other
key materials or components  through the  acquisition  of a supplier or expanded
manufacturing facilities of its own.

         PATENTS AND TRADEMARKS

         The  Company  relies,  in  part,  upon  patents,   trade  secrets,  and
proprietary knowledge as well as personnel policies and employee confidentiality
agreements  concerning  inventions and other creative  efforts to develop and to
maintain  its  competitive  position.  The  Company  does not  believe  that its
business is dependent upon any patent,  patent pending, or license,  although it
believes  that trade secrets and  confidential  know-how may be important to the
Company's scientific and commercial success.

         The Company plans to file for patents,  copyrights,  and  trademarks in
the United  States and in  appropriate  countries  to protect  its  intellectual
property  rights whenever  possible.  The Company holds the rights to two United
States patents and has Japanese and German patent applications  pending relating
to one of its image  couplers and holds the rights to a United  States patent to
one of its endoscopes. The Company has received jointly with a customer a patent
relating to one of its night-vision  designs. The Company will assign its rights
under this night-vision  patent to such customer for night-vision  applications.
The Company knows of no infringements of its patents. Although the Company plans
to protect  any patents it has from  infringement,  it may not be able to pursue
such  protection  for  economic  reasons.  While the Company  believes  that its
pending  applications relate to patentable devices or concepts,  there can be no
assurance  that  patents  will be  issued  or that  any  patents  issued  can be
successfully  defended or will effectively  limit the development of competitive
products and services.

         Although  the  Company  seeks to protect its  proprietary  information,
there can be no assurance that others will not either develop  independently the
same  or  similar  information  or  gain  access  to the  Company's  proprietary
information  or that  disputes will not arise as to  proprietary  rights to such
information.

         The Company's  products may now or in the future  infringe upon others'
patents or  proprietary  technology.  The  Company's  defense of any such claims
could have a material, adverse effect on the Company.

                                       -6-
3145003.02

<PAGE>



         EMPLOYEES

         As of June 30, 1996, the Company had fifty-five full-time employees and
one part-time employee.

         CUSTOMERS

         Sales  to the  Company's  three  largest  customers,  in terms of total
sales, during fiscal year 1996 were approximately 42%, 14% and 12%. Sales to the
Company's two largest customers, in terms of total sales during fiscal year 1995
were approximately 43% and 18%.

         ENVIRONMENTAL PROTECTION AND THE EFFECT OF EXISTING OR PROBABLE 
         GOVERNMENT REGULATIONS ON THE BUSINESS

         The Company's  operations  are subject to a variety of federal,  state,
and local laws and  regulations  relating to the discharge of materials into the
environment  or otherwise  relative to the protection of the  environment.  From
time to time the  Company  uses a small  amount of  hazardous  materials  in its
operations.  Although the Company  believes that it complies with all applicable
environmental  laws and  regulations,  any  failure to comply with such laws and
regulations could have a material,  adverse effect on its capital  expenditures,
earnings, and competitive position.

         NEED FOR GOVERNMENT APPROVAL OF PRINCIPAL PRODUCTS OR SERVICES AND
         EFFECT OF EXISTING OR PROBABLE GOVERNMENT REGULATIONS ON THE BUSINESS

         The Company  currently  sells and markets  four medical  products,  the
marketing of which may require the permission of the United States Food and Drug
Administration ("FDA"). Pursuant to the Company's notification to the FDA of its
intent to market its  laparoscope,  additional  types of endoscopes which it has
developed and is developing, image coupler,  beamsplitter, and adapters, the FDA
has  determined  that each such device is  substantially  equivalent to a device
marketed in  interstate  commerce and that the Company may market such  devices,
subject to the general  controls  provisions of the Food, Drug and Cosmetic Act.
Furthermore,  the  Company  plans to market  additional  endoscopes  and related
medical  products that may require the FDA's permission to market such products.
The Company  may also  develop  additional  products or seek to sell some of its
current or future  medical  products  in a manner that  requires  the Company to
obtain  the  permission  of the  FDA to  market  such  products,  as well as the
regulatory  approval or license of other federal,  state,  and local agencies or
similar agencies in other countries.  There can be no assurance that the Company
will be able to maintain the FDA's  permission to market its current products or
to obtain such  regulatory  permission,  approvals,  or licenses  for any of its
other  products.  Furthermore,  potential  adverse FDA regulation  affecting the
Company  which might  arise from future  legislation  or  administrative  action
cannot be predicted.  In addition, FDA regulations may be established that could
prevent or delay  regulatory  clearances or approval of the Company's  products.
The  inability  of the Company to secure any  necessary  licenses or  regulatory
approvals or permission from the FDA could have a material adverse effect on its
business. The FDA has authority to conduct detailed inspections of manufacturing
plants in order to assure that "good manufacturing practices" are being followed
in the manufacture of medical devices,  to require periodic reporting of product
defects to the FDA, and to prohibit  the  exploitation  of devices  which do not
comply with law. Failure to comply with applicable regulatory

                                       -7-
3145003.02

<PAGE>



requirements can, among other things, result in fines, suspensions of regulatory
clearances or approvals,  product recalls, operating restrictions,  and criminal
prosecution.

ITEM 2.  DESCRIPTION OF PROPERTY

         The Company  conducts  its domestic  operations  at two  facilities  in
Gardner and  Fitchburg,  Massachusetts.  The  Gardner  facility is leased from a
corporation  owned by an  officer-shareholder-director  of the Company,  and the
Company's  lease expires in December  1999.  The  Fitchburg  facility is under a
three year lease which  commenced on November 1, 1995.  The Company rents office
space in Hong Kong for sales, marketing,  and supplier liaison activities of its
Hong Kong subsidiary.

         The Company  believes  these  facilities  are  adequate for its current
operations;  significant  increases in production or the addition of significant
equipment  additions  or  manufacturing  capabilities  in  connection  with  the
production of the Company's line of endoscopes and other products may,  however,
require  the  acquisition  or lease of  additional  facilities.  The Company may
establish  production  facilities   domestically  or  overseas  to  produce  key
assemblies or components,  such as lenses, for the Company's products.  Overseas
facilities  may  subject  the  Company  to  the  political  and  economic  risks
associated  with overseas  operations.  The loss of or inability to establish or
maintain  such  additional  domestic or overseas  facilities  could  materially,
adversely affect the Company's competitive position and profitability.

ITEM 3.  LEGAL PROCEEDINGS

         The Company and its  subsidiaries  and their  property are not party or
subject to any material pending legal proceedings.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

         No matters were submitted to a vote of the Company's  security  holders
during the fourth quarter of fiscal year 1996.

                 DIRECTORS AND EXECUTIVE OFFICERS OF THE COMPANY

         The Company's executive officers and directors are as follows:

                                         Position with the Company
Name                                     or Principal Occupation


Richard E. Forkey                        President, Treasurer, and
                                         Director

Jack P. Dreimiller                       Senior Vice President,
                                         Finance and Chief Financial
                                         Officer

Robert C. Meinhold                       Vice President, Sales and Marketing

                                       -8-
3145003.02

<PAGE>



Edward A. Benjamin                       Director and Clerk.  Mr. Benjamin is a
                                         partner in the law firm of Ropes
                                         & Gray, Boston, Massachusetts

Joel R. Pitlor                           Director.  Mr. Pitlor is president of
                                         J.R. Pitlor, a management consulting
                                         firm based in Cambridge, Massachusetts.

Robert R. Shannon                        Director.   Mr. Shannon is a professor
                                         at the Optical Sciences Center of the
                                         University of Arizona in Tuscon,
                                         Arizona.


                                     PART II

ITEM 5.           MARKET FOR COMMON EQUITY AND RELATED
                  STOCKHOLDER MATTERS

         The  Company's  common  stock  currently  trades  on the  Boston  Stock
Exchange  under the symbol  "POC" and is listed on the National  Association  of
Securities Dealers Automated  Quotation (NASDAQ) System under the symbol "POCI."
From January 1991 to December  1991, the Boston Stock Exchange was the principal
market in which the  Company's  stock was publicly  traded.  Since January 1992,
NASDAQ has been the principal  market in which the  Company's  stock is publicly
traded.  The high and low sales  prices  for the  Company's  stock for each full
quarterly period within the two most recent fiscal years were as follows:
<TABLE>
<CAPTION>
<S>              <C>                  <C>                  <C>                  <C>

                        1995                                           1996
                        ----                                           ----

Quarter           High                 Low                  High                 Low
                  ----------------------------------------------------------------------

First             $1 7/8               $1 1/4               $1 7/8               $1 1/8

Second            $1 5/8               $1 1/4               $1 7/8               $1 1/4

Third             $1 7/16              $1 1/8               $2                   $1 1/4

Fourth            $1 9/16              $1                   $2                   $1 1/8

</TABLE>

         As of August 31, 1996 there were approximately 110 holders of record of
the Company's  common stock. The Company has never paid a dividend on its common
stock and does not intend to pay a dividend in the foreseeable future.



                                       -9-
3145003.02

<PAGE>



ITEM 6.       MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
              AND RESULTS OF OPERATIONS

IMPORTANT FACTORS REGARDING FORWARD-LOOKING STATEMENTS

         When  used in this  discussion,  the words  "believes",  "anticipates",
"intends to", and similar  expressions are intended to identify  forward-looking
statements. Such statements are subject to certain risks and uncertainties which
could  cause  actual  results to differ  materially  from those  projected.  See
"Important  Factors  Regarding   Forward-Looking   Statements"  filed  with  the
Company's  Quarterly  Report on Form 10-QSB for the period ending March 31, 1996
as Exhibit 99 and incorporated herein by reference. Readers are cautioned not to
place undue reliance on these forward-looking  statements which speak only as of
the date hereof.  The Company  undertakes no obligation to release  publicly the
result of any revisions to these forward-looking statements which may be made to
reflect  events  or  circumstances  after  the date  hereof  or to  reflect  the
occurrence of unanticipated events.

LIQUIDITY AND CAPITAL RESOURCES

         For the  year  ended  June  30,  1996,  the  Company's  cash  and  cash
equivalents  increased by approximately  $90,000 to $2,618,000.  The increase in
cash and cash  equivalents was due to cash generated by operating  activities of
approximately  $817,000,  less capital  expenditures of approximately  $616,000,
increases in other  assets,  primarily  patents,  of  approximately  $60,000 and
repayment of a capital lease obligation of approximately $51,000.

         During the quarter  ending March 31, 1996,  the Company  entered into a
five-year  capital lease  obligation  for the  acquisition  of optical thin film
coating equipment totaling approximately $299,000.

         The  Company  intends to continue  devoting  significant  resources  to
internally-funded research and development spending on both new products and the
improvement of existing  products.  The Company also intends to devote resources
to the marketing  and product  support of its  endoscope  product line,  and the
development of new methods of  distribution.  These  investments may temporarily
result in negative cash flow,  but the Company  anticipates  that the results of
these efforts will translate into increased revenues and profits.

         Furthermore,  depending  upon the market  acceptance  of the  Company's
products,  the  Company  believes  that  it  may be  obligated  to  acquire  new
facilities,  add additional manufacturing or research and development equipment,
or acquire a business  that  manufactures  or sells to the  Company  components,
materials,   supplies,   or  services  used  in  the   manufacture,   marketing,
distribution,  or  servicing  of the  Company's  new  products,  as  well as the
Company's existing products.

         The Company  continues to maintain a secured line of credit of $500,000
available with a bank at 1/4% over the prime rate.

         The Company's cash and cash  equivalents  and available lines of credit
are considered  sufficient to support working  capital and investment  needs for
the foreseeable future.



                                      -10-
3145003.02

<PAGE>



FISCAL YEAR 1996 RESULTS OF OPERATIONS

         Total revenues for the fiscal year 1996 were approximately  $8,055,000,
an increase of approximately $477,000 or 6.3%, over fiscal year 1995.

         The  revenue  increase  over the prior year was due to higher  sales of
medical products (up 30.3%) and higher sales of night vision products (up 1.8%),
partially  offset  by lower  sales of  industrial  products  (down  23.2%).  The
increase in sales of medical products was primarily attributable to higher sales
of  endocouplers,  which  increased  by 89% for the year to record  levels.  The
reduction in  industrial  sales was due  primarily to lower sales of  industrial
lenses to a significant  customer.  This customer accounted for 12%, 18%, and 7%
of  the  Company's  total  revenues  for  fiscal  years  1996,  1995  and  1994,
respectively. Future sales to this customer, if any, are uncertain at this time.

         Gross profits decreased by approximately  $123,000 in fiscal year 1996,
and as a percentage of revenues,  decreased  from 34.1% to 30.6% compared to the
previous  year. The decrease in gross profit was due primarily to an unfavorable
shift in sales mix away from industrial  products,  which have relatively higher
gross margins than other product lines,  and higher  occupancy and  depreciation
expenses related to equipment and manufacturing facilities additions.

         For the fiscal years ended June 30, 1996, 1995 and 1994,  approximately
45%, 45% and 43% of the Company's  total  revenues,  respectively,  were derived
from  production  and  development  contracts  and  subcontracts  involving  the
Government  and its  agencies.  The  Company's  current  Government  business is
substantially   comprised  of  subcontracts  with  one  customer  consisting  of
night-vision  advanced  development  programs  on  a  cost-plus-fixed-fee  basis
extending  approximately through September 1996, and two fixed-price  production
subcontracts   for   night-vision   lens  systems  with   deliveries   scheduled
approximately through September, 1997. The Government may terminate a government
contract at any time,  with or without  cause.  After  expiration of the current
subcontracts,  there can be no assurance that the  Government  will award future
contracts or subcontracts or the customers to which it sells.

         Selling, general and administrative expenses increased by approximately
$191,000 or 10% in fiscal year 1996  compared to fiscal year 1995.  The increase
was due primarily to higher  spending on new product  research and  development,
principally related to medical products, which increased by 19% to approximately
$433,000 in fiscal year 1996, higher  advertising  expenditures  targeted at the
industrial marketplace, and higher depreciation and amortization expenses.

         Interest  expense  relates   primarily  to  capital  lease  obligations
incurred in the third quarter of fiscal years 1994 and 1996.

         Interest income increased by approximately  $32,000 in fiscal year 1996
due to the higher investment base of cash equivalents and higher interest rates.

         The  provision  for income  taxes as a percentage  of pretax  income is
lower than the federal statutory income tax rate primarily due to recognition of
available tax credits and future tax deductions not previously benefited.


                                      -11-
3145003.02

<PAGE>



FISCAL YEAR 1995 RESULTS OF OPERATIONS

         Total revenues for fiscal year 1995 were approximately  $7,578,000,  an
increase of approximately $446,000 or 6.3%, over fiscal year 1994.

         The revenue  increase  over the prior year was due  primarily to higher
sales of industrial  products.  Sales of OEM medical and  night-vision  products
were approximately  equivalent to the prior year. Within the OEM medical product
line,  sales  of  endoscopes,   while  still  relatively  small,   increased  by
approximately 70% over the prior year.

         Gross profit increased by  approximately  $665,000 in fiscal year 1995,
and as a  percentage  of  revenues,  increased  from 26.9% to 34.1%  compared to
fiscal year 1994. The higher gross profit percentage in fiscal year 1995 was due
primarily to a favorable  shift in sales mix to industrial  products  which have
relatively  higher gross  margins,  and to the  recording in fiscal year 1994 of
certain   one-time   start-up  costs  related  to  a   night-vision   production
subcontract.

         Selling, general and administrative expenses increased by approximately
$176,000 or 10% in fiscal year 1995  compared to fiscal year 1994.  The increase
was due primarily to higher  spending on new product  research and  development,
principally related to medical products, which increased by 88% to approximately
$363,000 in fiscal year 1995.

         Interest  expense in fiscal year 1995 and 1994  related  primarily to a
capital lease obligation  incurred in the third quarter of fiscal year 1995, and
was higher due to a full year of expense in 1995 versus three months in 1994.

         Interest income increased by approximately  $48,000 in fiscal year 1995
due to the higher investment base of cash equivalents and higher interest rates.

         The  provision  for income taxes in fiscal year 1995  differed from the
amount  computed  when  applying the United  States  federal  income tax rate to
income before taxes,  due  primarily to the  utilization  in fiscal 19995 of net
operating loss and tax credit carryforwards.


ITEM 7.  CONSOLIDATED FINANCIAL STATEMENTS

         The  Consolidated  Financial  Statements are filed on pages 13 to 26 of
this Form 10-KSB.

                                      -12-
3145003.02

<PAGE>



               PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

                        CONSOLIDATED FINANCIAL STATEMENTS
                          AS OF JUNE 30, 1996 AND 1995
                         TOGETHER WITH AUDITORS' REPORT


                                      -13-
3145003.02

<PAGE>


                    REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS




To Precision Optics Corporation, Inc.:

We have audited the accompanying consolidated balance sheets of Precision Optics
Corporation,  Inc. (a Massachusetts corporation) and subsidiaries as of June 30,
1996  and  1995,  and  the  related   consolidated   statements  of  operations,
stockholders'  equity and cash  flows for each of the three  years in the period
ended June 30, 1996. These financial  statements are the  responsibility  of the
Company's  management.  Our  responsibility  is to  express  an opinion on these
financial statements based on our audits.

We  conducted  our  audits  in  accordance  with  generally   accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion,  the financial  statements  referred to above present fairly, in
all material respects,  the financial position of Precision Optics  Corporation,
Inc.  and  subsidiaries  as of June 30, 1996 and 1995,  and the results of their
operations  and their cash flows for each of the three years in the period ended
June 30, 1996, in conformity with generally accepted accounting principles.



/s/ Arthur Andersen
Boston, Massachusetts
July 24, 1996


                                      -14-
3145003.02

<PAGE>

<TABLE>




                                            PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

                                            CONSOLIDATED BALANCE SHEETS--JUNE 30, 1996 AND 1995
<CAPTION>
<S>                                   <C>           <C>          <C>                                 <C>              <C>           




                         ASSETS           1996          1995      LIABILITIES AND STOCKHOLDERS' EQUITY      1996           1995
CURRENT ASSETS:                                                  CURRENT LIABILITIES:
   Cash and cash equivalents         $  2,617,813  $  2,527,846   Accounts payable                    $    829,428    $    467,961
     Accounts receivable (net of                                  Accrued payroll                           81,990          65,006
     allowance for doubtful accounts                              Accrued profit sharing and bonuses        93,938         140,000
     of approximately $82,000 and                                 Accrued professional services             49,360          48,855
     $86,000 in l996 and 1995,                                    Accrued vacation                          5l,88l          44,932
     respectively)                      1,139,804     1,416,371   Accrued warranty expense                  50,000          45,000
   Inventories                          1,863,694     1,468,479   Accrued income taxes                      35,383          50,784
   Deferred tax asset                     119,000        52,000   Other accrued liabilities                 51,638          40,654
   Prepaid expenses                        44,684        22,874   Current portion of capital
   Refundable income taxes                 30,276           -      lease obligation                         82,678          28,686  
                                       ----------      --------                                           --------         --------
                                                                  
                                                                  

         Total current assets           5,815,271      5,487,570       Total current liabilities         1,326,296         931,878
                                        ---------      ---------                                         ---------       ---------

PROPERTY AND EQUIPMENT, AT COST:
   Machinery and equipment              2,049,758      1,244,304  CAPITAL LEASE OBLIGATION, NET           
                                                                   OF CURRENT PORTION                      278,949          84,829
   Leasehold improvements                 420,230        344,718                                         ---------       ---------
   Vehicles                                44,742         33,654
   Furniture and fixtures                 102,976         88,003
                                        ---------      ----------
                                        2,617,706      1,710,679  COMMITMENTS (Notes 3 and 4)

   Less--Accumulated depreciation       1,531,228      1,246,843
   and amortization                     ---------      ---------
                                        1,086,478        463,836
                                        ---------      ---------  STOCKHOLDERS' EQUITY:
                                                                   Common stock, $.01 par value-
OTHER ASSETS:                                                       Authorized--10,000,000 shares
   Cash surrender value of life                                     Issued and outstanding--5,980,502      59,805          59,805
   insurance policies                      52,851         49,057   Additional paid-in capital           5,145,655       5,145,655
   Patents                                125,995         84,000
   Deferred costs, net                      2,025          3,909   Retained earnings (deficit)            271,915        (133,795)
                                       ----------        --------                                       ---------        ---------

         Total other assets               180,871        136,966     Total stockholders' equity         5,477,375       5,071,665
                                        ---------       ---------                                       ---------        ---------

                                     $  7,082,620     $6,088,372                                     $  7,082,620    $  6,088,372
                                        =========      =========                                        =========       =========

</TABLE>

                          The  accompanying  notes are an integral part of these
consolidated financial statements.




                                       15
3145003.02

<PAGE>
<TABLE>


                                PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

                                       CONSOLIDATED STATEMENTS OF OPERATIONS
                                 FOR THE YEARS ENDED JUNE 30, 1996, 1995 AND 1994
<CAPTION>
<S>                                                                <C>                <C>              <C>



- ---------
                                                                          1996               1995               1994

REVENUES                                                            $    8,055,271     $    7,578,097    $    7,131,888

COST OF GOODS SOLD                                                       5,592,871          4,992,785         5,211,575
                                                                         ---------          ---------         ---------

           Gross profit                                                  2,462,400          2,585,312         1,920,313

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES                             2,128,155          1,937,497         1,761,103
                                                                         ---------          ---------         ---------

         Operating income                                                  334,245            647,815           159,210

INTEREST EXPENSE                                                           (16,639)            (9,598)           (4,356)

Interest Income                                                            124,104             92,499            44,203
                                                                       ------------        ------------       ----------

         Income before provision for income taxes                          441,710            730,716           199,057

Provision for Income Taxes                                                  36,000            150,000              -
                                                                       ------------        ------------       ----------  
         Net income                                                   $    405,710       $    580,716      $    199,057
                                                                      ============       ============      ============

INCOME PER COMMON AND COMMON EQUIVALENT SHARE                       $          .07     $          .10    $          .03

                                                                    ==============     ==============     ==============

WEIGHTED AVERAGE COMMON AND COMMON EQUIVALENT
SHARES OUTSTANDING                                                       6,116,569          6,066,366          6,085,275
                                                                       ===========        ===========        ===========
</TABLE>


               The accompanying notes are an integral part of these consolidated
financial statements.



                                       16
3145003.02

<PAGE>



<TABLE>


                                PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

                                   CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
 
                                  FOR THE YEARS ENDED JUNE 30, 1996, 1995 AND 1994

<CAPTION>
<S>                                <C>             <C>           <C>             <C>               <C> 

                                                                                   RETAINED
                                                                 ADDITIONAL        EARNINGS            TOTAL
                                    NUMBER OF       COMMON         PAID-IN       (ACCUMULATED      STOCKHOLDERS'
                                     SHARES          STOCK         CAPITAL         DEFICIT)           EQUITY


  BALANCE, JUNE 30, 1993               5,707,626      $  57,076     $ 4,974,289     $ (913,568)       $ 4,117,797

   Proceeds from exercise of
   options to purchase common
   stock                                272,876           2,729          23,366               -            26,095

   Net income                                 -               -               -         199,057           199,057
                                    -----------     -----------    ------------       ---------         ---------

  BALANCE, JUNE 30, 1994              5,980,502          59,805       4,997,655       (714,511)         4,342,949

   Tax benefit from exercise of
   options to purchase common
   stock                                      -               -         148,000               -           148,000

   Net income                                 -               -               -         580,716           580,716
                                    -----------     -----------     -----------       ---------         ---------

  BALANCE, JUNE 30, 1995              5,980,502          59,805       5,145,655       (133,795)         5,071,665

   Net income                                 -               -               -         405,710           405,710
                                  -------------   -------------    -----------        ---------         ---------


  BALANCE, JUNE 30, 1996              5,980,502     $    59,805     $ 5,145,655     $   271,915       $ 5,477,375
                                      =========     ===========     ===========     ===========       ===========
</TABLE>


                The   accompanying   notes  are  an   integral   part  of  these
consolidated financial statements.



                                       17
3145003.02

<PAGE>

<TABLE>


                                PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

                                        CONSOLIDATED STATEMENTS OF CASH FLOWS
 
                                  FOR THE YEARS ENDED JUNE 30, 1996, 1995 AND 1994
<CAPTION>
<S>                                                                  <C>              <C>             <C>

                                                                          1996             1995           1994
  CASH FLOWS FROM OPERATING ACTIVITIES:
    Net income                                                        $   405,710      $  580,716     $  199,057
    Adjustments to reconcile net income to net cash provided
    by (used in) operating activities-
       Depreciation and amortization                                      308,275         184,849        121,212
       Deferred income taxes                                             (67,000)        (52,000)              -
       Changes in assets and liabilities-
           Accounts receivable                                            276,567       (123,485)      (467,119)
           Inventories                                                  (395,215)          86,378      (187,446)
           Prepaid expenses                                              (21,810)         (4,091)          8,499
           Refundable income taxes                                       (30,276)               -         31,069
           Accounts payable                                               361,467          16,732       (94,173)
           Accrued payroll                                                 16,984         (5,527)        (2,246)
           Accrued profit-sharing and bonuses                            (46,062)         140,000              -
           Accrued professional services                                      505         (3,238)       (23,523)
           Accrued income taxes                                          (15,401)          47,722              -
           Accrued restructuring                                                -         (4,695)      (133,466)
           Other accrued liabilities                                       22,933        (17,413)         11,158
                                                                      -----------   ------------    ------------

              Net cash provided by (used in) operating activities         816,677         845,948      (536,978)
                                                                      -----------     -----------   -----------

  CASH FLOWS FROM INVESTING ACTIVITIES:
    Purchases of property and equipment                                 (615,798)       (115,602)      (171,206)
    (Increase) decrease in other assets                                  (59,844)        (47,717)          1,718
                                                                    ------------     -----------    ------------

              Net cash used in investing activities                     (675,642)       (163,319)      (169,488)
                                                                    ------------     -----------    -----------

  CASH FLOWS FROM FINANCING ACTIVITIES:
    Repayment of capital lease obligation                                (51,068)        (26,603)       (11,461)
    Tax benefit from stock options exercised                                    -         148,000              -
    Proceeds from issuance of common stock                                      -               -         26,095
                                                                  --------------- ---------------   ------------

              Net cash provided by (used in) financing activities        (51,068)         121,397         14,634
                                                                     -----------     ------------   ------------

  NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS                     89,967         804,026      (691,832)

  CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR                          2,527,846       1,723,820      2,415,652
                                                                      -----------    ------------    -----------

  CASH AND CASH EQUIVALENTS, END OF YEAR                              $ 2,617,813      $2,527,846     $1,723,820
                                                                      ===========      ==========     ==========

  SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
    Cash paid (received) during the year for-
       Interest                                                      $     16,639    $      9,598   $      4,356
                                                                     ============    ============   ============
       Income taxes                                                   $   151,325    $      6,278   $   (29,613)
                                                                      ===========    ============   ============

  SUPPLEMENTAL SCHEDULE OF NONCASH INVESTMENT ACTIVITIES:
    Capital lease obligation                                         $    299,180  $            -    $   151,579
                                                                     ============  ==============    ===========
</TABLE>


              The accompanying  notes are an integral part of these consolidated
financial statements.


                                       18
3145003.02

<PAGE>



               PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 1996



  (1)    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

         Nature of Business

         Precision Optics Corporation,  Inc. (the Company) designs, manufactures
         and sells  optical  systems,  components  and thin-film  coatings.  The
         Company  conducts  business  in  one  industry  segment  only  and  its
         customers are primarily  domestic.  The Company's products and services
         fall into two principal  areas:  medical  products for use by hospitals
         and  physicians  and advanced  optical  system  design and  development
         services and products,  primarily  under  contract  either  directly or
         indirectly with the United States Government.

         Principles of Consolidation

         The accompanying consolidated financial statements include the accounts
         of the Company and its two wholly owned subsidiaries,  Precise Medical,
         Incorporated,  which was  inactivated  during  fiscal 1994,  and Wood's
         Precision  Optics  Corporation,   Ltd.  All  significant   intercompany
         accounts and transactions have been eliminated in consolidation.

         Revenues

         Revenues for industrial and medical  products sold in the normal course
         of  business  are  recognized  upon  shipment.  Contract  revenues  are
         recognized under the percentage-of-completion method. The percentage of
         completion is determined by computing the percentage of the actual cost
         of work performed to the  anticipated  total contract  costs, or on the
         basis of units  shipped.  When the  estimate on a contract  indicates a
         loss, the Company's  policy is to record the entire loss in the current
         period.

         Cash and Cash Equivalents

         The Company includes in cash equivalents all highly liquid  investments
         with  original  maturities  of  three  months  or less  at the  time of
         acquisition.  Cash  equivalents  at June  30,  1996  and  1995  include
         approximately $1,455,000 and $1,880,000, respectively, of United States
         Treasury bills.



                                       19
3145003.02

<PAGE>



               PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 1996

                                   (Continued)

  (1)    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

         Inventories

         Inventories  are stated at the lower of cost  (first-in,  first-out) or
         market and include  material,  labor and  manufacturing  overhead.  The
         components of inventories are as follows at June 30, 1996 and 1995:

<TABLE>
<CAPTION>
<S>                         <C>                 <C>

                                   1996               1995

Raw material                 $    1,282,924        $   915,932
Work-in-progress                    502,658            391,318
Finished goods                       78,112            161,229
                               ------------         ----------

                                $ 1,863,694        $ 1,468,479
                                ===========        ===========
</TABLE>

         Depreciation and Amortization

         The Company  provides for  depreciation  and amortization by charges to
         operations,  using the  straight-line  and  declining-balance  methods,
         which  allocate the cost of property and  equipment  over the following
         estimated useful lives:

                                                              ESTIMATED
                        ASSET CLASSIFICATION                 USEFUL LIFE
                      Machinery and equipment                  5-7 Years
                      Leasehold improvements               Life of lease
                      Vehicles                                   3 Years
                      Furniture and fixtures                     5 Years

         Significant Customers and Concentration of Credit Risk

         Revenues from the Company's three largest customers were  approximately
         42%, 14% and 12%,  respectively,  of total  revenues for the year ended
         June 30, 1996.  Revenues from the Company's two largest  customers were
         approximately 43% and 18%, respectively, of total revenues for the year
         ended June 30, 1995.  Revenues from the Company's largest customer were
         approximately  51% of total  revenues for the year ended June 30, 1994.
         No  other  customers  accounted  for  more  than  10% of the  Company's
         revenues in each of the three years  ended June 30,  1996.  At June 30,
         1996 and 1995,  receivables  from the Company's  largest  customer were
         approximately 58% and 44% of total accounts receivable, respectively.

                                       20
3145003.02

<PAGE>



               PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 1996

                                   (Continued)


(1)      SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

         Significant Customers and Concentration of Credit Risk (Continued)

         Approximately  44%, 45% and 43% of the Company's revenues for the years
         ended June 30,  1996,  1995 and 1994,  respectively,  were derived from
         sales to agencies of the government or customers  that supply  agencies
         of the government.

         Research and Development

         Research and  development  costs,  which are expensed as incurred,  are
         included in selling,  general and  administrative  expenses and include
         direct costs plus overhead.  Such costs totaled approximately $433,000,
         $363,000 and $193,000 for the years ended June 30, 1996, 1995 and 1994,
         respectively.

         Income per Common and Common Equivalent Share

         Income per common and common  equivalent share is computed based on the
         weighted  average  number of common  and common  equivalent  shares (if
         dilutive)  outstanding  during each year.  The  difference  between the
         weighted average shares outstanding under the primary and fully diluted
         methods is not significant.

         Foreign Currency Translation

         The Company translates certain accounts and financial statements of its
         foreign  subsidiary in accordance  with SFAS No. 52,  Foreign  Currency
         Translation.   The  functional   currency  of  the  Company's   foreign
         subsidiary is the United States dollar. Accordingly,  translation gains
         or losses are reflected in the accompanying  consolidated statements of
         operations and have not been significant.

         Other Assets

         Patents  and  deferred  costs are  carried  at cost,  less  accumulated
         amortization of approximately  $60,000 and $44,000 at June 30, 1996 and
         1995,  respectively.  Such costs are amortized using the  straight-line
         method over their legal or estimated  useful lives,  generally  five to
         seventeen years.



                                       21
3145003.02

<PAGE>



               PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 1996

                                   (Continued)

(1)      SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

         Use of Estimates

         The  preparation of financial  statements in conformity  with generally
         accepted  accounting  principles  requires management to make estimates
         and  assumptions  that  affect  the  reported  amounts  of  assets  and
         liabilities and disclosure of contingent  assets and liabilities at the
         date of the financial  statements and the reported  amounts of revenues
         and expenses during the reporting  period.  Actual results could differ
         from those estimates.

         Reclassifications

         Certain  reclassifications  have been made to the prior years' balances
         to conform with the current year's presentation.

(2)      LINE OF CREDIT

         At June 30, 1996,  the Company had available a demand line of credit of
         $500,000 at an interest  rate equal to the bank's  prime rate (8.25% at
         June 30, 1996) plus 0.25%.  At June 30, 1996,  there were no borrowings
         outstanding  under this line of credit.  Borrowings  under this line of
         credit are  secured by all  assets of the  Company.  The line of credit
         expires on November 30, 1996; however, the Company anticipates renewal.

(3)      CAPITAL LEASE OBLIGATION

         At June 30, 1996,  future  minimum lease  payments  under capital lease
obligations are as follows:
<TABLE>
<CAPTION>
<S>                       <C>                                                            <C>

                           FISCAL YEAR                                                       AMOUNT

                          1997                                                             $ 109,000
                          1998                                                               109,000
                          1999                                                                93,920
                          2000                                                                72,808
                          2001                                                                42,474
                                                                                         -----------
                                    Total minimum lease payments                             427,202

                          Amount representing interest                                      (65,575)
                                                                                          ---------
                                    Present value of minimum lease payments                  361,627

                          Less--Current portion                                               82,678
                                                                                          ----------
                                                                                          $  278,949
                                                                                          ==========
</TABLE>
                                                                               

                                       22
3145003.02

<PAGE>



               PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 1996

                                   (Continued)


(3)      CAPITAL LEASE OBLIGATION (Continued)

         Capital  leases  are  secured  by all  assets  of the  Company  under a
         security agreement subordinate to the Company's demand line of credit.

(4)      RELATED PARTY TRANSACTIONS AND COMMITMENTS

         The Company leases one of its facilities from a corporation owned by an
         officer of the  Company.  The lease,  which was renewed  during  fiscal
         1995, terminates in December 1999 and requires lease payments of $9,000
         per month.  The  Company may  terminate  the lease as of the end of any
         calendar year during the term by providing written notice to the lessor
         by June 30 of such year.

         Total future  minimum rental  payments  under all operating  leases for
fiscal 1997 are $208,000.

         Rent expense on operating leases was approximately  $187,000,  $144,000
         and  $133,000  for the  years  ended  June 30,  1996,  1995  and  1994,
         respectively.

         The Company  paid fees to a director of  approximately  $60,000  during
         each of fiscal 1996,  1995 and 1994 for  consulting  services.  Another
         director is a partner in a law firm that has performed  legal  services
         for the Company during fiscal 1996, 1995 and 1994.

(5)      STOCKHOLDERS' EQUITY

         In  conjunction  with previous  equity  offerings,  the Company  issued
         warrants to acquire a total of 320,000 shares of common stock, of which
         warrants for 23,500 shares  expired  during  fiscal 1996.  Warrants for
         76,500  shares have an exercise  price of $4.50 per share and expire on
         January 15,  1997.  Warrants for 220,000  shares  expire on October 23,
         1998 and have an  exercise  price of $1.375 per  share.  As of June 30,
         1996, all of these warrants were exercisable.

         During 1989, the  stockholders  approved a stock option plan (the Plan)
         for key  employees.  The  Plan,  as  amended,  authorizes  the grant of
         options to  purchase up to  1,110,000  shares of the  Company's  common
         stock at an exercise  price not less than 100% of the fair market value
         per share at the date of grant.  Options  granted are exercisable for a
         period  determined  by the Board of  Directors,  not to exceed 10 years
         from the date of  grant.  At June 30,  1996,  200,748  shares of common
         stock were available for future grants under the Plan.



                                       23
3145003.02

<PAGE>

<TABLE>


                                PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

                                    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                                   JUNE 30, 1996

                                                    (Continued)


(5)      STOCKHOLDERS' EQUITY (Continued)

         The  following is a summary of  transactions  in the Plan for the three
years ended June 30, 1996:
<CAPTION>
                       <S>                                           <C>                    <C>

                                                                        NUMBER                 OPTION PRICE
                                                                       OF SHARES                 PER SHARE

                        Options outstanding, June 30, 1993                582,876            $  .067-  $5.6875
                           Exercised                                    (272,876)                  .067-.50
                           Canceled                                      (15,000)                   4.4375
                                                                      -----------              -------------

                        Options outstanding, June 30, 1994                295,000               3.500-  5.6875
                           Granted                                        395,000                   1.3750
                           Canceled                                     (295,000)               3.500-  5.6875
                                                                       ----------              ---------------

                        Options outstanding, June 30, 1995                395,000                   1.375
                           Granted                                         60,000               1.375 - 1.50
                                                                        ---------              ---------------

                        Options outstanding, June 30, 1996                455,000            $  1.375 - $1.50
                                                                        =========            ================

                        Options exercisable, June 30, 1996                164,834            $  1.375 - $1.50

                                                                        =========            ================

</TABLE>

         In  addition,  the  Company  has  granted  options  outside  the  Plan,
         primarily to directors and consultants at 100% of the fair market value
         per share at the date of grant.  During fiscal 1995, options for 30,000
         shares at $1.375 per share,  including options for 15,000 shares issued
         to replace  existing  options,  were  granted to two  directors  of the
         Company,  which became  exercisable  in four equal annual  installments
         beginning on December 15, 1994.  Also during  fiscal 1995,  options for
         35,000 shares at $1.375 per share,  including options for 15,000 shares
         issued to replace existing options, were granted to two consultants and
         one former employee of the Company; 15,000 such shares were exercisable
         at December 15, 1994,  and 20,000  shares  became  exercisable  in four
         equal annual installments beginning on December 15, 1994. During fiscal
         1996,  options for 60,000  shares at $1.30 per share were  granted to a
         consultant  to the  Company,  which  became  exercisable  in five equal
         annual  installments  beginning on July 31, 1995.  As of June 30, 1996,
         options for 221,617 shares were  outstanding at exercise prices ranging
         from $.067 to $5.6875  per share,  of which  148,617  were  exercisable
         within the same exercise price range.


                                       24
3145003.02

<PAGE>



               PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 1996

                                   (Continued)

(6)      INCOME TAXES

         The Company  accounts for income taxes in accordance with SFAS No. 109,
         Accounting for Income Taxes,  whereby a deferred tax asset or liability
         is  measured  by the enacted tax rates that would be in effect when any
         differences between the financial statement and tax bases of assets and
         liabilities reverse.

         The  provision  for  income  taxes  in  the  accompanying  consolidated
         statements of operations  consists of the following for the three years
         ended June 30, 1996:
<TABLE>
<CAPTION>
                    <S>                                        <C>               <C>             <C>


                                                                    1996             1995              1994

                     Current-
                         Federal                                 $  67,000         $  52,000      $        -
                         State                                       3,000                 -               -
                         Foreign                                    33,000             2,000               -
                                                                ----------        ----------      -----------
                                                                   103,000            54,000               -

                     Deferred-
                         Federal                                  (67,000)          (52,000)               -

                     Charge in lieu of income taxes                      -           148,000               -
                                                             -------------         ---------      -----------
                                                                 $  36,000          $150,000      $        -
                                                                 =========          ========      ==========
</TABLE>

         A  reconciliation  of the  federal  statutory  rate  to  the  Company's
         effective  tax rate  for the  three  years  ended  June 30,  1996 is as
         follows:
<TABLE>
<CAPTION>
               <S>                                                           <C>          <C>          <C>

                                                                                1996         1995         1994

               Income tax provision at federal statutory rate                   34.0%        34.0%        34.0%

               Increase (decrease) in tax resulting from--
                  Utilization of operating loss carryforwards                    -          (3.1)            -
                  Operating loss carryforwards not benefited                     -            -           14.0
                  Temporary items with no tax benefit                            7.3          -          (49.5)
                  Tax credits utilized                                          (4.1)       (6.4)            -
                  Change in valuation allowance                                (35.5)       (7.1)            -
                  Prior year tax adjustments                                     5.0          -              -
                  Other                                                          1.5         3.1           1.5
                                                                             -------      -------      -------

                         Effective tax rate                                      8.2%        20.5%           -%
                                                                             ========      =======      =======
                                       25
</TABLE>
3145003.02

<PAGE>



               PRECISION OPTICS CORPORATION, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                  JUNE 30, 1996

                                   (Continued)


(6)      INCOME TAXES (Continued)

         The  components of the net deferred tax asset at June 30, 1996 and 1995
         are approximately as follows:
<TABLE>
<CAPTION>
         <S>                                                         <C>                     <C>

                                                                          1996                   1995

         Reserves and accruals not yet deducted for tax
         purposes                                                     $  175,000              $  265,000
         Other temporary differences                                      17,000                  17,000
                                                                      ----------              ----------
                                                                         192,000                 282,000

         Valuation allowance                                            (73,000)               (230,000)
                                                                     ----------              ----------

                 Net deferred tax asset                               $  119,000              $   52,000
                                                                      ==========              ==========
</TABLE>


         A full  valuation  allowance was provided upon the adoption of SFAS No.
         109  in  1993  due  to the  uncertainty  at  that  time  of the  future
         realizability of the Company's  deferred tax asset.  During fiscal 1996
         and 1995, the Company  reduced the valuation  allowance by $157,000 and
         $52,000,  respectively,  which represents recognition of the portion of
         the  deferred  tax asset that can be  carried  back to offset the prior
         years' tax liabilities, if necessary.

(7)      PROFIT SHARING PLAN

         The Company has a defined contribution  profit-sharing plan that covers
         all  eligible  employees.  The  Company  has  accrued  and  expensed an
         employer  contribution  to this  plan of  $50,000  in  fiscal  1996 and
         $50,000 in fiscal 1995. No employer  contributions  were made in fiscal
         1994.

ITEM 8.           CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
                  ACCOUNTING AND FINANCIAL DISCLOSURE.

                  None.

                                       26
3145003.02

<PAGE>




                                    PART III

ITEM 9  DIRECTORS, EXECUTIVE OFFICERS, AND CONTROL PERSONS; Compliance with
        --------------------------------------------------
        Section 16(a) of the Exchange Act.  The Company will furnish to the
        Securities and Exchange Commission a definitive Proxy Statement (the
        "Proxy Statement") not later than 120 days after the close of its fiscal
        year ended June 30, 1996.  The information required by this item is
        incorporated herein by reference to the Proxy Statement.

ITEM 10 EXECUTIVE COMPENSATION.  The information required by this item is 
        -----------------------
        incorporated herein by reference to the Proxy Statement.

ITEM 11 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
        ---------------------------------------------------
        MANAGEMENT.  The information required by this item is incorporated
        herein by reference to the Proxy Statement.

ITEM 12 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.  The information
        ----------------------------------------------
        required by this item is incorporated herein by reference to the Proxy
        Statement.

                                     PART IV

ITEM 13 EXHIBITS AND REPORTS ON FORM 8-K.
        ---------------------------------

(a)  Exhibits.
     The exhibits listed below are filed with or incorporated by reference
     in this report.

      3.1      Articles of Organization of the Company<F1>
      3.2      By-laws of Precision Optics Corporation, Inc.<F2>
      4.1      Specimen common stock certificate<F1>
      4.2      Private Placement Selling Agent Common Stock Warrant No. 4 dated
               April 28, 1992 issued to  James L. Davis and Schedule 1 of
               Omitted Documents<F3>
      4.3      Initial Public Offering Common Stock Purchase Warrant No. 3 date
               July 10, 1992 issued to John C. Michalak and Schedule 2 of 
               Omitted Documents<F3>
      4.4      Warrant No. U-1 to Purchase Shares of Common Stock of the Company
               dated January 24, 1992 issued to Nathan Newman and Schedule 3 of
               Omitted Documents<F3>
      4.5      Promissory Note dated December 5, 1991 between the Company and
               The First National Bank of Boston<F4>
      4.6      Agreement Restricting Sale of Stock dated January 15, 1992 by and
               among Richard E. Forkey, the Company, Kennedy, Mathews, Landis, 
               Healy & Pecora Incorporated, and Equity Securities Trading
               Co., Inc.<F3>
      4.7      Option Share Escrow Agreement by and among the Company, the
               Commissioner of Commerce for the State of Minnesota, Resource
               Bank & Trust, and David McNally and Schedule of Omitted
               Documents<F4>
      10.1     Lease  dated June 29,  1984  between  the Company and Equity,
               First  Amendment to  Commercial  Lease dated June 25, 1990,  and
               letter  agreement  dated June 25, 1990 renewing such lease<F1>

                                       27
3145003.02

<PAGE>



       10.2     Precision Optics Corporation, Inc. 1989 Stock Option Plan 
                amended to date (the Plan")<F5>
       10.3     Stock Option to Joel R. Pitlor dated May 30, 1989 and letter
                agreement dated June 25, 1990 amending such option<F1>
       10.4     Stock Option to Robert R. Shannon dated June 25, 1990<F2>
       10.5     Stock Option to Joel R. Pitlor dated April 7, 1992 and Schedule
                4 of Omitted Documents<F3>
       10.6     Form of the Company's Non-disclosure and Non-Competition
                Agreement<F1>
       10.7     Three separate life insurance policies on the life of
                Richard E. Forkey<F1>
       10.8     Agreement dated October 19, 1991 between the Boston Stock
                Exchange and the Company<F2>
       10.9     Agreement dated November 18, 1991 between The NASDAQ Stock
                Market and the Company<F3>
       10.10    Master Lease Finance Agreement dated November 3, 1993 between
                the Company and BancBoston Leasing.<F5>
       10.11    Second  Amendment  to  Commercial  Lease  between the
                Company and Equity dated December 9, 1994.
       10.12    Lease dated November 1, 1995 between the Company and 
                Janice M. Bouchard, Trustee of Authority Drive Realty Trust.
       21       Subsidiaries of Precision Optics Corporation, Inc.
       99       Important Factors Regarding Forward-Looking Statements.<F6>
[FN]

<F1>        Incorporated herein by reference to the Company's Registration
            Statement on Form S-18 (No. 33-36710-B).
<F2>        Incorporated herein by reference to the Company's 1991 Annual Report
            on Form 10-KSB.
<F3>        Incorporated herein by reference to the Company's 1992 Annual Report
            on Form 10-KSB.
<F4>        Incorporated herein by reference to the Company's Registration 
            Statement on Form S-1 (No.33-43929).
<F5>        Incorporated herein by reference to the Company's 1994 Annual Report
            on Form 10-KSB.
<F6>        Incorporated herein by reference to the Company's Quarterly Report
            on Form 10-QSB for the quarter ended March 31, 1996.
[/FN]

(b)         Reports on Form 8-K.

            None.

                                       28
3145003.02

<PAGE>




                                   SIGNATURES

In  accordance  with  Section 13 or 15(d) of the Exchange  Act,  the  registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

Date:  September 19, 1996                   PRECISION OPTICS CORPORATION, INC.



                                            By:/s/ Richard E. Forkey
                                             Richard E. Forkey
                                             Chairman of the Board and Chief
                                              Executive Officer

In  accordance  with the Exchange  Act, this report has been signed below by the
following  persons on behalf of the  registrant and in the capacities and on the
dates indicated.



By:/s/ Richard E. Forkey                     By:/s/ Jack P. Dreimiller
   Richard E. Forkey                          Jack P. Dreimiller
   President, Treasurer, and                  Senior Vice President, Finance
   Director (Principal                        and Chief Financial Officer
   Executive Officer)                         (Principal Financial and
                                              Accounting Officer)

September 19, 1996                            September 19, 1996
- ------------------------------                ------------------
Date                                          Date


By:/s/ Joel R. Pitlor                         By:/s/ Edward A. Benjamin
   Joel R. Pitlor                              Edward A. Benjamin
   Director                                    Director

September 19, 1996                            September 19, 1996
- --------------------------------              ------------------
Date                                          Date


By:/s/ Robert R. Shannon
   Robert R. Shannon
   Director

September 19, 1996
- --------------------------------
Date

                                       29
3145003.02

<PAGE>



                                INDEX TO EXHIBITS

3.1      Articles of Organization of the Company<F1>
3.2      By-laws of Precision Optics Corporation, Inc.<F2>
4.1      Specimen common stock certificate<F1>
4.2      Private Placement Selling Agent Common Stock Warrant No. 4 dated
         April 28, 1992 issued to  James L. Davis and Schedule 1 of Omitted
         Documents<F3>
4.3      Initial Public Offering Common Stock Purchase Warrant No. 3 dated
         July 10, 1992 issued to John C. Michalak and Schedule 2 of Omitted
         Documents<F3>
4.4      Warrant No. U-1 to Purchase Shares of Common Stock of the Company dated
         January 24, 1992 issued to Nathan Newman and Schedule 3 of Omitted
         Documents<F3>
4.5      Promissory Note dated December 5, 1991 between the Company and The
         First National Bank of Boston.<F4>
4.6      Agreement Restricting Sale of Stock dated January 15, 1992 by and among
         Richard E. Forkey, the Company, Kennedy, Mathews, Landis, Healy &
         Pecora Incorporated, and Equity Securities Trading Co., Inc.<F3>
4.7      Option Share Escrow Agreement by and among the Company, the
         Commissioner of Commerce for the State of Minnesota, Resource Bank & 
         Trust, and David McNally and Schedule of Omitted Documents<F4>
10.1     Lease  dated June 29,  1984  between  the Company and
         Equity,  First  Amendment to  Commercial  Lease dated
         June 25, 1990,  and letter  agreement  dated June 25,
         1990 renewing such lease<F1>
10.2     Precision Optics Corporation, Inc. 1989 Stock Option Plan amended to
         date (the "Plan")<F5>
10.3     Stock Option to Joel R. Pitlor dated May 30, 1989 and letter agreement
         dated June 25, 1990 amending such option<F1>
10.4     Stock Option to Robert R. Shannon dated June 25, 1990<F2>
10.5     Stock Option to Joel R. Pitlor dated April 7, 1992 and Schedule 4 of
         Omitted Documents<F3>
10.6     Form of the Company's Non-disclosure and Non-Competition Agreement<F1>
10.7     Three separate life insurance policies on the life of 
         Richard E. Forkey<F1>
10.8     Agreement dated October 19, 1991 between the Boston Stock Exchange and
         the Company<F2>
10.9     Agreement dated November 15, 1991 between The NASDAQ Stock Market and
         the Company<F3>
10.10    Master Lease Finance Agreement dated November 3, 1993 between the
         Company and BancBoston Leasing.<F5>
10.11    Second  Amendment  to  Commercial  Lease  between the
         Company and Equity dated December 9, 1994.
10.12    Lease dated November 1, 1995 between the Company and
         Janice M. Bouchard, Trustee of Authority Drive Realty Trust.
21       Subsidiaries of Precision Optics Corporation, Inc.
99       Important Factors Regarding Forward-Looking Statements.<F6>

[FN]

<F1>  Incorporated herein by reference to the Company's Registration Statement 
      on Form S-18 (No. 33-36710-B).
<F2>  Incorporated herein by reference to the Company's 1991 Annual Report on 
      Form 10-KSB.
<F3>  Incorporated herein by reference to the Company's 1992 Annual Report on
      Form 10-KSB.
<F4>  Incorporated herein by reference to the Company's Registration Statement
      on Form S-1 (No.33-43929).

                                       30
3145003.02

<PAGE>


<F5>  Incorporated herein by reference to the Company's 1994 Annual Report on
      Form 10-KSB.
<F6>  Incorporated herein by reference to the Company's Quarterly Report on
      Form 10-QSB for the quarter ended March 31, 1996.

[/FN]

                                       31
3145003.02

<PAGE>

                                                                EXHIBIT 10.12

                                COMMERCIAL LEASE

        Lease  Agreement  entered into as of this 1st day of November,  1995, by
and between Janice M.  Bouchard,  Trustee of Authority  Drive Realty Trust,  180
Authority Drive, Fitchburg, Massachusetts, under declaration of trust dated July
13, 1995, and recorded in the Worcester North District Registry Of Deeds at Book
2732, Page 52 (hereinafter  referred to as the "Lessor"),  and Precision  Optics
Corporation,   Inc.,  22  East  Broadway,  Gardner,  Massachusetts  (hereinafter
referred to as the "Lessee").

        1. The Lessor does hereby lease, demise and let unto the Lessee those
premises described as follows:

        Approximately  Eight Thousand,  Four Hundred Sixteen (8,416) square feet
        within  the  building  located  at  190  Authority   Drive,   Fitchburg,
        Massachusetts,  together with the right to use in common with the Lessor
        and any other tenants of Lessor,  the  landscaped  grounds,  parking and
        truck  access to the  premises  located  at 180 - 190  Authority  Drive,
        Fitchburg,  Massachusetts  (hereinafter  referred  to  as  the  "demised
        premises"  or the "leased  premises"),  being a portion of the  premises
        described in a Deed dated July 13, 1995,  and recorded in the  Worcester
        North  District  Registry  Of Deeds at Book  2732,  Page 57.  Please see
        Exhibit "A" of the Commercial Lease attached hereto.

         The Lessor and Lessee agree that the leased  premises shall be measured
(in accordance with BOMA/ANSI  standards) after the date of commencement of this
Lease to confirm the actual square footage, which will then be used for purposes
of the annual fixed rental rate  established  in Paragraph 3 below.  (Any credit
due Lessee because the actual amount of space is less than the amount  indicated
in this paragraph will be deducted by Lessee against the next  installment(s) of
rent due under this Lease and any payment owed by Lessee because of underpayment
shall be paid by Lessee  with the next  installment(s)  of rent due  under  this
Lease.

         2. The term of the Lease  shall be for three  (3) years  commencing  on
November 1, 1995, and ending on October 31, 1998.

         3. The  annual  fixed  rent  shall be paid by  Lessee  to  Lessor at an
address provided by Lessor to Lessee in equal monthly installments as follows:
<TABLE>
<CAPTION>
<S>                   <C>                              <C>                            <C>

                                                                                       AMOUNT PER
    YEAR              ANNUAL                           MONTHLY                        SQUARE FOOT
    ----              ------                           -------                        -----------
       1          $50,496.00                         $ 4,208.00                             $6.00
       2          $53,020.08                         $ 4,418.50                             $6.30
       3          $55,671.84                         $ 4,639.32                             $6.62
</TABLE>

                                       -1-
3150414.01

<PAGE>




         4. In addition to the annual fixed rent,  Lessee shall pay its pro rata
share of real estate taxes  (quarterly  or as invoiced by the City  Assessor for
the City of Fitchburg),  fire and casualty insurance and common area maintenance
(driveways,  parking lots, landscaping and the like), which pro rata share shall
be equal to  thirty-three  (33%)  percent  (approximate  percentage  of building
leased by Lessee) of said costs attributable to the building and land located at
190 Authority Drive,  Fitchburg,  Massachusetts,  01420. Lessee shall pay Lessor
its pro rata share of such  expenses  within  twenty  (20) days of receipt of an
invoice from Lessor (including  appropriate  backup such as copies of tax bills,
casualty insurance invoices and other matters).

         5. Upon the  execution of this  Commercial  Lease,  Lessee shall pay to
Lessor a security  deposit in the amount of $8,000.00,  which  security  deposit
shall be held in escrow by Lessor,  with all interest  being retained by Lessor,
for the term of this Lease.  Lessor shall return the security  deposit to Lessee
within thirty (30) days of the  expiration  of the term of this Lease,  provided
Lessee is not in default  of the terms of this  Commercial  Lease.  In the event
Lessee is in default of any of the terms of this Commercial Lease.  Lessor shall
use the  security  deposit  to cure the  defaults  and shall  return  any unused
portion to Lessee within a reasonable time, not to exceed sixty (60) days, after
said defaults are completely cured.

         6. Lessee  shall be  responsible  for and pay, as they become due,  all
bills for electricity,  water,  sewer and other utilities (whether they are used
for furnishing heat or other purposes) that are furnished to the leased premises
and all bills for fuel,  solely to the extent such bills relate to actual use of
such  utilities by Lessee with respect to its occupancy of the leased  premises.
Notwithstanding  this provision,  Lessee acknowledges and recognizes any and all
of its additional  obligations  concerning utilities which are contained in this
Commercial Lease.

        Upon execution of this Commercial Lease,  Lessor shall make arrangements
with an insured  contractor to separately meter the gas consumption  between the
demised premises and the remaining unleased area of the premises situated at 190
Authority Drive, Fitchburg, Massachusetts. Lessor agrees that such work shall be
completed within thirty (30) days of the execution of this Commercial Lease.

         Upon  Lessor  leasing  said  remaining  unleased  area of the  premises
situated at 190 Authority  Drive,  Fitchburg,  Massachusetts  to another tenant,
other than Priority  Manufacturing,  Inc. and/or Mar-Lee Mold, Inc., which shall
use  this  remaining  space  for  temporary  storage  of  plastic  resin  during
construction  activity at 180 Authority  Drive,  Fitchburg,  Massachusetts,  the
Parties shall make arrangements  with an insured  contractor to separately meter
the  electrical  consumption  between the  demised  premises  and the  remaining
portion  of  the  premises   situated  at  190   Authority   Drive,   Fitchburg,
Massachusetts.  Until such time as said  unleased  premises  are leased,  Lessee
shall pay any and all bills for  electricity  for the premises at 190  Authority
Drive,  Fitchburg,  Massachusetts.  Notwithstanding the terms of this paragraph,
Lessor agrees to monitor the activities of Priority Manufacturing, Inc. and/or

                                       -2-
3150414.01

<PAGE>



Mar-Lee Mold, Inc. to assure that they efficiently operate the lighting when
moving materials within said remaining unleased area.

         Lessor and Lessee shall equally divide the proposed utility  separation
cost up to a total cost of $4,500.00.  Should the actual cost exceed  $4,500.00,
Lessee shall not be responsible  for any amount in excess of $2,250.00,  and the
Lessor  shall pay all such excess.  Upon  execution  of this  Commercial  Lease,
Lessee shall pay to Lessor  $1,125.00,  which  represents  one-half (1/2) of the
anticipated costs to Lessee of the separation of the gas metering.

         Upon execution of this  Commercial  Lease,  Lessee shall make immediate
arrangements  with the City Of  Fitchburg  for  direct  billing of the water and
sewer use of 190 Authority Drive,  Fitchburg,  Massachusetts,  to Lessee. In the
event said  remaining  unleased  area of the premises  situated at 190 Authority
Drive, Fitchburg, Massachusetts, are leased, Lessor and/or said new tenant shall
make arrangements with the City Of Fitchburg for direct billing of the water and
sewer use of 190 Authority Drive, Fitchburg,  Massachusetts,  to said new tenant
and thereafter the bills for water and sewer  consumption  shall be prorated for
all tenants of 190 Authority Drive,  Fitchburg,  Massachusetts,  based on actual
use.

         7.  As  the  utility   room  for  190   Authority   Drive,   Fitchburg,
Massachusetts  is  situated  within  the  demised  premises,  in the event  said
remaining  unleased  area is  leased,  Lessee  shall  allow  any  new  tenant(s)
reasonable access to the utility room for all necessary purposes associated with
the utility room.

         8.  Lessee   intends  to  utilize  the  demised   premises   for  light
manufacturing and office purposes, shipping and receiving and for uses ancillary
thereto. No trade or occupation shall be conducted on the leased premises or use
made thereof which shall be unlawful, improper, noisy, offensive, or contrary to
any law or  regulation,  including but not limited to the rules and  regulations
promulgated by the City Of Fitchburg  Redevelopment Authority for 231 Industrial
Park; the Zoning By Laws of the City of Fitchburg,  Massachusetts;  the laws and
regulations of the Commonwealth Of  Massachusetts,  including M.G.L. c. 21E; and
the laws and  regulations of the United States Of America.  In addition,  Lessee
agrees  that no use  shall  be  made of the  leased  premises  which  materially
interferes  with the use being made of the  premises  located  at 180  Authority
Drive,  Fitchburg,  Massachusetts and any use which may be made of the remaining
unleased  area  of the  premises  located  at 190  Authority  Drive,  Fitchburg,
Massachusetts.

         9. Lessee shall indemnify and hold harmless Lessor from and against any
loss,  damage,  liability,  costs  or  expense,  including  without  limitation,
reasonable  attorney's  fees,  suffered  by Lessor  by  reason  of the  release,
discharge,  storage or use by Lessee,  its agents,  and  invitees on the demised
premises  or the  property  located  at 180 - 190  Authority  Drive,  Fitchburg,
Massachusetts, after the commencement date of this Commercial Lease, of any oil,
hazardous  materials  or  hazardous  waste,  as defined  from time to time under
applicable state and federal laws or regulations.

                                       -3-
3150414.01

<PAGE>



        Likewise,  Lessor  shall  indemnify  and hold  harmless  Lessee from and
against  any  loss,  damage,  liability,  costs or  expense,  including  without
limitation,  reasonable  attorney's  fees,  suffered  by Lessee by reason of the
release,  discharge,  storage or use by Lessor,  its agents, and invitees on the
demised  premises  or  the  property  located  at  180  - 190  Authority  Drive,
Fitchburg,  Massachusetts of any oil, hazardous materials or hazardous waste, as
defined  from  time  to  time  under   applicable  state  and  federal  laws  or
regulations.

        Upon  execution of this  Commercial  Lease,  Lessee shall provide Lessor
with a written list of any and all hazardous materials,  as that term is defined
by M.G.L.  c. 21E,  that  Lessee  intends  to use  and/or  store at the  demised
premises.

         10. In executing  this  Commercial  Lease,  Lessee fully and completely
understands  and is  aware  that the  remaining  unleased  area of the  premises
located at 190  Authority  Drive,  Fitchburg,  Massachusetts,  which is directly
adjacent  to the demised  premises,  may be utilized  for  manufacturing,  light
manufacturing,  assembly,  light assembly and/or warehouse  purposes.  While not
making any guaranty,  Lessor shall use all reasonable efforts to ensure that any
use made of the remaining unleased area of the premises located at 190 Authority
Drive,  Fitchburg,  Massachusetts,  will not materially  interfere with Lessee's
proposed use of the demised premises.

         11. Lessee shall procure at Lessee's sole expense all necessary permits
and licenses, including any and all accessory expenses associated with obtaining
said permits and licenses,  before using and/or  occupying the demised  premises
and before  undertaking  any work on the demised  premises.  Lessee shall do all
such work in a good and workmanlike manner,  employing materials of good quality
which substantially conform to the structure and materials currently existing at
the demised premises.

         12. The Lessee shall not assign or sublet this Commercial Lease without
first  obtaining  on each  occasion  the written  consent of the  Lessor,  which
consent shall not be unreasonably withheld, conditioned or delayed. In the event
that  Lessor  consents  to any  assignment  or  subletting  of any or all of the
demised  premises  and the rent and other sums and  considerations  received  by
Lessee on account of such assignment or sublease of the demised  premises or any
part  thereof,  as the case may be,  shall  exceed  the  Annual  Fixed  Rent and
additional  rent due  hereunder,  Lessee shall pay to Lessor,  as an  additional
charge,  fifty percent (50%) of such excess less  Lessee's  reasonable  expenses
incurred to obtain such sublease or assignment, including brokerage commissions,
advertising and reasonable attorney's fees. Such excess shall be paid monthly as
received by Lessee. No such assignment or subletting shall in any way impair the
continuing  primary  liability  of  Lessee  hereunder,  and  no  consent  to any
assigning or subletting in a particular  instance shall be deemed to be a waiver
of the  obligation  to obtain  the  Lessor's  approval  in the case of any other
assignment  or  subletting.  Notwithstanding  anything  to the  contrary  in the
foregoing or in this Commercial Lease elsewhere  contained,  Lessee may, without
either notice to or consent of Lessor,  assign this  Commercial  Lease or sublet
all or any portion of the demised premises in connection with any

                                       -4-
3150414.01

<PAGE>



merger,  consolidation,  reorganization  or  other  corporate  restructuring  of
Lessee,  or any sale of all or substantially  all the stock or assets of Lessee,
provided only that the successor  corporation or entity acquiring Lessee's stock
or assets agrees to be bound by all the terms and provisions of this  Commercial
Lease for the benefit of Lessor.

         13. The Lessee  agrees to  maintain  the  leased  premises  in the same
condition as they are at the  commencement  of the term or as they may be put in
during  the term of this  Lease,  reasonable  wear and tear,  damage by fire and
other casualty only  excepted.  Whenever  necessary,  Lessee shall replace plate
glass and other glass therein, acknowledging that the leased premises are now in
good order and the glass whole.  The Lessee shall not permit the leased premises
to be overloaded, damaged, stripped, or defaced, or suffer any waste.

         14. The Lessor agrees to maintain the structural integrity of the roof,
foundation  and exterior  walls so as not to materially  interfere with Lessee's
use of the premises excepting only those  circumstances where damage to same has
been caused by the  negligence,  acts or omissions  of the Lessee,  its assigns,
agents or employees.

         15. The Lessee  agrees to keep the  demised  premises in good order and
repair,  and in at  least  as  good  order  and  repair  as  they  are in on the
commencement  date,  reasonable use and wear and damage by fire or casualty only
excepted; and to keep all fixtures and equipment now or hereafter on the demised
premises,  including,  without  limitation,  all interior walls, all floors, all
heating,  plumbing,  electrical,  air conditioning,  and mechanical fixtures and
equipment serving only the demised premises, in good order and repair, and in at
least  as good  order  and  repair  as  they  are in on the  commencement  date,
reasonable  wear and tear and damage by fire or casualty only  excepted;  and to
make all repairs and  replacements  and to do all other work  necessary  for the
foregoing purposes,  both ordinary and extraordinary.  It is further agreed that
the exception of reasonable  use and wear shall not apply so as to permit Lessee
to keep the demised  premises  in anything  less than  suitable,  efficient  and
usable  condition  considering  the nature of the demised  premises  and the use
reasonably made thereof, or in less than good order, repair, and condition.

         16. Lessee agrees to pay its pro rata share,  as defined in Paragraph 4
of this Commercial Lease, for any expenditures  regarding the replacement of any
fixtures and equipment which serve the premises situated at 190 Authority Drive,
Fitchburg,  Massachusetts.  To the  extent  these are  capital  expenditures  as
generally  defined  by  generally  accepted  accounting  principles  and  may be
amortized,  any tax benefits shall be fairly  apportioned  between Lessor and/or
any new tenant and Lessee such that Lessee  shall only pay its pro rata  portion
of the annual charge-off of such capital expenditures determined by dividing the
original cost of the capital  expenditure  by the number of years of useful life
thereof (the useful life shall be reasonably  determined by Lessor in accordance
with  generally  accepted  accounting  principles and practices in effect at the
time of acquisition of the capital item).


                                       -5-
3150414.01

<PAGE>



         17. The Lessee  shall not permit any use of the leased  premises  which
will make  voidable any  insurance on the property of which the leased  premises
are a part, or on the contents of said  property,  or which shall be contrary to
any law or  regulation,  from time to time,  established by the New England Fire
Insurance Rating Association, or any similar body succeeding to its powers.

         In the event Lessee's use or occupancy of the demised  premises  causes
any increase in insurance  premiums for the buildings or premises located at 180
- -  190  Authority  Drive,  Fitchburg,   Massachusetts,  Lessee  shall  pay  such
additional costs.

         18,  The  Lessee  agrees  to  maintain  in full  force a  comprehensive
commercial  liability insurance policy in the amount of $3,000,000.00  (combined
single  limit)  written by an insurance  company  reasonably  acceptable  to the
Lessor, under which the Lessee and Lessor are named as insured's or loss payees.
The Lessee shall deposit with the Lessor  certificates  for such insurance at or
prior to the  commencement of the term, and thereafter  within thirty days prior
to the expiration of any such policies.  All such insurance  certificates  shall
provide  that such policy  shall not be canceled  without at least ten (10) days
prior written notice to each assured named therein.  Each said insurance  policy
shall, to the extent available,  include a provision by which the insurer waives
all rights of subrogation against the Lessor. Any insurance policy maintained by
Lessor  concerning the demised  premises  shall, to the extent  available,  also
include a  provision  by which the  insurer  waives  all  rights of  subrogation
against the Lessee.

         19. The Lessee shall not make  structural  alterations  or additions to
the leased premises, but may make non-structural alterations provided the Lessor
consents thereto, in writing,  which consent shall not be unreasonably withheld,
conditioned  or  delayed.  All  such  allowed  alterations  shall be made at the
Lessee's  expense  and  shall  be in  quality  at  least  equal  to the  present
construction. Lessee shall not permit any mechanics' liens, or similar liens, to
remain upon the leased premises for labor and materials  furnished to Lessee, or
claimed  to have  been  furnished  to  Lessee,  in  connection  with work of any
character  performed or claimed to have been  performed at the  direction of the
Lessee  and shall  cause any such lien of record to be  released  or bonded  off
forthwith without cost to the Lessor.  Any such alterations or improvements made
by the Lessee shall become the property of the Lessor at the  termination of the
occupancy as provided  herein,  unless such  alterations or improvements  may be
removed by Lessee without  damage to the  structural  integrity of the premises.
Upon removal of same,  Lessee  agrees to restore the  premises to its  condition
prior to the making of the alteration or improvement.

         20. The Lessor and  Lessor's  designees,  shall have the right to enter
upon the demised  premises,  during normal  business  hours,  for the purpose of
inspecting same and determining the need for repairs.  If Lessee is obligated to
make repairs,  pursuant to the terms hereof,  Lessor may demand that Lessee make
same  forthwith,  and if Lessee refuses or neglects to commence such repairs and
complete same with reasonable dispatch, after such demand,

                                       -6-
3150414.01

<PAGE>



Lessor may (but shall not be required  to) make or cause such repairs to be made
and  shall not be  responsible  to  Lessee  for any loss or  damage  that may be
accrued to  Lessee's  stock or business by reason  thereof.  If Lessor  makes or
causes such necessary  repairs to be made, Lessee agrees to pay Lessor forthwith
as additional rent, for the cost thereof, and in default of such payment, Lessor
shall have the remedies  provided  herein as well as other remedies  provided by
law.

         21. The Lessee agrees to indemnify and save  harmless,  the Lessor from
and against all claims of whatever  nature  arising from any act,  omission,  or
negligence of the Lessee or Lessee's contractors,  licensee's, agents, servants,
or employee's, or arising from any accident, injury or damage whatsoever, caused
to any  person,  or to the  property of any  person,  occurring  during the term
hereof,  in or about the demised  premises.  This  indemnity  and hold  harmless
agreement shall include  indemnity  against all reasonable  costs,  expenses and
liabilities  incurred  in or in  connection  with any such claim or  proceedings
brought thereon, and the defense thereof, including reasonable attorney's fees.

         The  Lessee  shall save the  Lessor  harmless  from all loss and damage
occasioned by the use or escape of water or by the bursting of pipes,  or by any
nuisance made or suffered on the leased premises,  unless such loss is caused by
the negligence of the Lessor. The removal of snow and ice from the sidewalks and
entrance  ways  bordering  upon  the  leased  premises  shall  be  the  Lessee's
responsibility.

         22. The Lessee also agrees to keep Lessee's  fixtures,  merchandise and
equipment  insured  against  loss or  damage  by fire or other  casualty.  It is
understood that Lessee assumes all risks of damage to Lessee's  property arising
from any cause whatsoever, including, but not limited to loss by theft.

         23.  Should a  substantial  portion of the leased  premises,  or of the
property of which they are apart,  be damaged by fire or other  casualty,  or be
taken by eminent domain, the Lessor may elect to terminate this Lease. When such
fire,  casualty,  or taking  renders the leased  premises  or a portion  thereof
substantially  unsuitable  for  their  intended  use,  a just and  proportionate
abatement of the rent shall be made.  Lessee may elect to  terminate  this Lease
if:

                  a. The Lessor fails to give written  notice within thirty (30)
                  days of its  intention to restore the leased  premises;  or b.
                  The Lessor fails to restore the leased premises to a condition
                  substantially  suitable for their  intended use within  ninety
                  (90) days of said fire, casualty, or
                  taking.

         If less than a substantial  portion of the leased  premises,  or of the
property  of which they are a part,  is damaged  by fire or other  casualty,  or
taken by eminent  domain,  the Lessor shall,  as promptly as  practicable,  make
arrangements to repair, reconstruct or replace the

                                       -7-
3150414.01

<PAGE>



destroyed  portions of the leased  premises or the  property of which they are a
part, to as nearly as possible the condition prior to such destruction.

         The Lessor  reserves,  and the Lessee grants to the Lessor,  all rights
which the Lessee may have for damages or injury to the leased  premises  for any
taking by eminent domain, except for damage to the Lessee's fixtures,  property,
or equipment.

         24. In the event  that  Lessee  shall  default  in the  payment  of any
installment  of rent or other sums herein  provided  for, and said default shall
continue for seven (7) days after  written  notice to Lessee from Lessor of such
default,  or if the Lessee shall default in the observance or performance of any
other of the Lessee's covenants,  agreements, or obligations hereunder, and such
default shall  continue for twenty (20) days after written notice to Lessee from
Lessor of such default, or if the Lessee shall be declared bankrupt or insolvent
according to the law, or shall enter an assignment for the benefit of creditors,
then the  Lessor  shall  have the right  thereafter  to enter and take  complete
possession of the leased  premises and to terminate this Lease and/or remove the
property of the Lessee,  without  prejudicing any other remedies available under
this Lease or at law for  arrears  of rent or other  damages.  The Lessee  shall
indemnify  the  Lessor  against  all loss of rent and other  payments  which the
Lessor may incur by reason of such termination during the residue of the term of
this Lease or any  extension.  If the Lessee shall default in the  observance or
performance  of any  conditions or covenants on the Lessee's part to be observed
or  performed  under or by virtue of any of the  provisions  of this Lease,  the
Lessor, without being under obligation to do so and without thereby waiving such
default,  may remedy  such  default  for the  account  and at the expense of the
Lessee.  If the Lessor makes any  expenditures or incurs any obligations for the
payment  of  money  in  connection  therewith,  including  but  not  limited  to
reasonable attorney's fees in instituting,  prosecuting and defending any action
or  proceedings,  such sums paid or obligations  incurred,  with interest at the
rate of twelve (12%) percent per annum and costs, shall be paid to the Lessor by
the Lessee forthwith as additional rent.

         25. The Lessee,  subject to the terms and conditions of this Lease,  on
payment of the rent and observing,  keeping, and performing all of the terms and
provisions of this Lease on their part to be observed, kept and performed, shall
lawfully,  peaceably  and  quietly  have,  hold,  occupy  and enjoy the  demised
premises  during the term hereof without  hinderance or rejection by any persons
claiming under Lessor.

         26. Any notice  from the  Lessor to the Lessee  relating  to the leased
premises,  or to the occupancy thereof,  shall be deemed duly served, if left at
the leased premises,  addressed to the Lessee, or mailed to the leased premises,
registered or certified mail,  return receipt  requested,  postage prepaid,  and
addressed to the Lessee.  Any notice to the Lessor by the Lessee relating to the
leased  premises  or to the  occupancy  thereof,  shall be deemed duly served if
mailed to the Lessor by registered or certified mail, return receipt  requested,
postage prepaid, and addressed to the Lessor at 180 Authority Drive,  Fitchburg,
Massachusetts,

                                       -8-
3150414.01

<PAGE>



01420,  or such other  address as the Lessor  may,  from time to time  advise in
writing, with a copy to John M. Dombrowski,  Esq., 32 School Street, Leominster,
Massachusetts, 01453.

         27. If the Lessee  wishes to continue its tenancy  after the end of the
leased  term,  he will  notify the Lessor in writing at least  ninety  (90) days
before the end of the lease term, and join in  negotiations as to the rental and
other terms of an extension or renewal.  If it fails to give such notice,  or if
the parties  are unable to agree on the terms of  continued  tenancy,  the Lease
shall end at the  conclusion  of the original  term.  Nothing  contained in this
paragraph  shall,  however,  obligate  the  Lessor to extend  the  period of the
Lessee's  occupancy,  or to  negotiate  new terms if it wishes for any reason to
have the Lease terminated at the end of the original term.

         28. The Lessee  shall at the  expiration  or other  termination  of the
Lease,   remove  all  Lessee's  goods  and  effects  from  the  leased  premises
(including,  without hereby limiting the generality of the foregoing,  all signs
or  lettering  affixed or painted by the  Lessee,  either  inside or outside the
leased premises). Lessee shall deliver to the Lessor the leased premises and all
keys, locks thereto,  and other fixtures connected therewith and all alterations
and additions made to or upon the leased premises, in the same condition as they
were at the  commencement  of the term,  or as they were put in during  the term
hereof,  reasonable  wear and tear and  damage  by fire or other  casualty  only
excepted.  In the event of the  Lessee's  failure to remove any of the  Lessee's
property from the premises,  Lessor is hereby  authorized,  without liability to
Lessee for loss or damage thereto, and at the sole risk of the Lessee, to remove
and store any of the  property  at  Lessee's  expense  or to retain  same  under
Lessor's  control or to sell at public or private sale,  without notice,  any or
all of the property not so removed and to apply the net proceeds of such sale to
the payment of any sums due hereunder, or to dispose of such property.

         29. The Lessor  shall in no event be in default in the  performance  of
any of its obligations  hereunder unless and until Lessor failed to perform such
obligations  within thirty (30) days, or such  additional  time as is reasonably
required to correct any such default  after  written  notice by Lessee to Lessor
pursuant to paragraph 26 of this Commercial  Lease properly  specifying  wherein
the Lessor has failed to perform any such obligation.

         30.  Failure  on the part of the  Lessor to  complain  of any action or
non-action on the part of the Lessee,  no matter how long the same may continue,
shall  never be deemed to be a waiver by Lessor of any of its rights  hereunder.
No  waiver  at any  time of any of the  provisions  hereof  by  Lessor  shall be
construed as a waiver of any of the other provisions  hereof and a waiver at any
time of any of the  provisions  hereof shall not be construed as a waiver at any
subsequent time of the same provisions.  The consent or approval of Lessor to or
of any action by Lessee  requiring  Lessor's  consent or  approval  shall not be
deemed to waive or render unnecessary  Lessor's consent or approval to or of any
subsequent similar act by Lessee.


                                       -9-
3150414.01

<PAGE>



         Similarly,  failure on the part of the Lessee to complain of any action
or  non-action  on the  part of the  Lessor,  no  matter  how  long the same may
continue,  shall  never be deemed to be a waiver by Lessee of any of its  rights
hereunder. No waiver at any time of any of the provisions hereof by Lessee shall
be construed as a waiver of any of the other  provisions  hereof and a waiver at
any time of any of the  provisions  hereof shall not be construed as a waiver at
any subsequent time of the same provisions. The consent or approval of Lessee to
or of any action by Lessor  requiring  Lessee's consent or approval shall not be
deemed to waive or render unnecessary  Lessee's consent or approval to or of any
subsequent similar act by Lessor.

        31. No payment by Lessee,  or acceptance  by Lessor,  of a lesser amount
then shall be due from  Lessee to Lessor  shall be treated  otherwise  than as a
payment on account.  The  acceptance  by Lessor of a check for a lesser  amount,
with an endorsement of statement thereon,  or upon any letter  accompanying such
check, that such lesser amount is payment in full shall be given no effect,  and
Lessor may accept such check  without  prejudice to any other rights or remedies
which Lessor may have against Lessee.

        32. If any term or provision of this Lease, or the  application  thereof
to any person or circumstance  shall to any extent be invalid or  unenforceable,
the  remainder of this Lease,  or the  application  of such term or provision to
persons  or  circumstances  other  than  those to which  it is held  invalid  or
unenforceable,  shall not be affected  thereby,  and each term and  provision of
this Lease shall be valid and be enforced to the  fullest  extent  permitted  by
law.

        33.  Lessee shall have the right of first  refusal to lease the unleased
adjacent  area  within 190  Authority  Drive,  Fitchburg,  Massachusetts,  which
consists of approximately  17,500 square feet. Lessor shall notify Lessee of any
offer from any other  prospective  tenant,  which Lessor in its sole  discretion
deems  tenable,  for said unleased  adjacent area and shall provide  Lessee with
copies of any written  offer or letter of intent  submitted  by the  prospective
tenant.  Lessee  shall  have the  option to match  this  offer  within  five (5)
business days of receipt of Lessor's  notice.  This right of first refusal shall
extend to each and every offer from any  prospective  tenant  deemed  tenable by
Lessor during the term of this Commercial Lease.

        34. Upon reasonable notice to Lessor and/or any subsequent tenant of the
said unleased  adjacent  area,  Lessee shall have the right to occasional use of
the loading  docks,  which docks are not  included in the demised  premises,  as
indicated on Exhibit A of this Commercial Lease, for the purposes of loading and
unloading various equipment and supplies.

        35. Lessee agrees to provide and pay for regular,  ongoing trash removal
service  adequate to ensure that the  demised  premises  are kept in a clean and
orderly  condition.  Lessee  agrees  that such trash  removal  service  shall be
performed by a vendor acceptable to Lessor.

        36. Lessee shall have the right to use twenty-five (25) designated 
parking spaces for itself, its employees, invitees, customers and other persons
visiting the demised premises,

                                      -10-
3150414.01

<PAGE>



which parking spaces are situated directly in front of the main entrance between
180 and 190 Authority  Drive,  Fitchburg,  Massachusetts,  as more  specifically
shown on Exhibit "B" of the Commercial Lease attached hereto.

         37. Within thirty (30) days of the execution of this Commercial  Lease,
Lessee  shall  construct  safety  railings  in said  loading  dock  area for the
protection of bottle gas storage, compressors and the like.

         38.  Lessor and Lessee  represent  and  warrant  each to the other that
neither has  employed  any broker  other than  Anderson-Howard  Commercial  Real
Estate,  54  Main  Street,  Leominster,   Massachusetts  with  respect  to  this
Commercial  Lease and each  shall  hold  harmless  the other  from any claim for
brokerage or other commission arising from any breach of the foregoing warranty.
Lessor shall pay all brokers fees of Anderson-Howard Commercial Real Estate.

         39. Except as herein  otherwise  expressly  provided,  the terms hereof
shall be  binding  upon and  shall  inure to the  benefit  of the  heirs,  legal
representatives,  successors  and assigns,  respectively,  of the Lessor and the
Lessee.

         40. This Lease shall be governed  exclusively by the provisions  hereof
and by the laws of the Commonwealth of Massachusetts,  as the same may from time
to time exist.

         41.  This  Lease  shall  be  subject  and  subordinate  to any  and all
mortgages, deeds of trust, and other instruments in the nature of a mortgage now
or at any time  hereafter  on the  property of which the leased  premises  are a
part, provided that Lessor shall use best efforts to obtain from the current and
any future holder of any  mortgage,  deed of trust or other  instrument  for the
benefit of Lessee a so-called recognition and non-disturbance  agreement in form
and  substance  reasonably  acceptable to such  mortgagee and to Lessee.  Lessee
shall, when requested,  promptly execute and deliver such written instruments as
shall be necessary to show the  subordination  of this Lease to said  mortgages,
deeds of trust, or other instruments in the nature of a mortgage.

         42. In the event  Lessor  decides to sell the  premises  located at 190
Authority Drive, Fitchburg, Massachusetts, Lessor agrees to notify Lessee of its
intention prior to advertising or listing the premises with a real estate broker
and to entertain any offers to purchase said premises from Lessee.

         43. This instrument  contains the entire agreement  between the parties
and supersedes all prior or contemporaneous  oral or written agreements,  and it
may not be modified except by a writing signed and/or executed by all parties.


                                      -11-
3150414.01

<PAGE>



         44.  Reference in this Lease agreement to the Lessee shall be deemed to
refer to the  Lessee or  Lessees  named  herein,  and if there are more than one
Lessee, their obligations hereunder shall be joint and several.

         IN WITNESS WHEREOF,  the parties hereto set their hands and seals as of
the lst day of November, 1995.

                                              Hereunto  duly  authorized,
                                              LESSOR:


                                              Janice M. Bouchard, Trustee of
                                              Authority Drive Realty Trust

                                              Hereunto  duly  authorized,
                                              LESSEE:




                                              Jack P. Dreimiller, Chief
                                              Financial Officer
                                              Precision Optics Corporation, Inc.

                                      -12-
3150414.01

<PAGE>



                                    EXHIBIT A

That certain  parcel of land located on the southerly  side of Authority  Drive,
Fitchburg,  Massachusetts,  shown as Lot 6B on the plan titled  "Plan of Land in
Fitchburg,  Massachusetts,  for Fitchburg Redevelopment Authority" dated June 7,
1982,  recorded in Worcester Northern District Registry of Deeds, Plan Book 256,
Plan 7, Large Plan Book 21, Plan 21, bounded and described as follows:

Beginning  at the  northeasterly  corner  thereof at the point in the  southerly
sideline of  Authority  Drive which is the most  northwesterly  corner of Lot 6C
shown in the plan recorded in said Registry of Deeds, Plan Book 264, Page 1,

THENCE S. 87(degree) 59' 42" W., along the southerly sideline of Authority
Drive, five hundred fifty-five and 63/100 (555.63) feet, to a point;

THENCE westerly,  along the southerly sideline of Authority Drive, by a curve to
the right with a radius of 530.00  feet,  eighty-five  and 00/100  (85.00)  feet
measured along the arc of the curve, to Lot 6A on said plan;

THENCE S. 2(degree) 48' 30" E., by Lot 6A, three hundred thirty-five and 84/100
(335.84) feet, to a corner at State Highway Route 2;

THENCE easterly along the State Highway by a curve to the right with a radius of
2,900.00  feet, six hundred  twenty-one and 32/100  (621.32) feet measured along
the arc of the curve, to a point;

THENCE S. 84(degree) 10' 13" E., along the State Highway fifteen and 85/100
(15.85) feet, to a corner, at said Lot 6C;

THENCE N. 2(degree) 00' 18" W., along said Lot 6C, three hundred forty-nine and
54/100 (349.54) feet to the place of beginning.

Containing 209,173 square feet.

EXCEPTING  from  the  above  described  parcel  of  land  (i.e.  Lot  6B) is the
triangular piece of land (located in the  southeasterly  corner of Lot 6B) taken
by the Commonwealth of  Massachusetts  (along with adjoining land) by the Notice
of Taking dated March 23, 1983  recorded in said  Registry of Deeds,  Book 1312,
Page 491.  See also Plan Book 261,  Page 13, Large Plan Book 22, Page 5, and, in
particular,  Parcel 4-17 on Sheet 4 of 10. The  approximate  description of said
triangular piece of land is:

BEGINNING at the  southeasterly  corner of Lot 6B as shown on said plan recorded
in said Registry of Deeds, Plan Book 256, Plan 7, Large Plan Book 21, Plan 21;

                                      -13-
3150414.01

<PAGE>


THENCE N. 2(degree) O' 18" W., beside Lot 6C referred to hereinabove 48.58 feet,
to the northerly sideline of the State Highway taking;

THENCE S. 72(degree) 13' 11" W., by the northerly sideline of the State Highway
taking 124.91 feet to the former location of the State Highway (said former
location being the southerly sideline of Lot 6B as described above);

THENCE  easterly by a curve to the right with a radius of 2,900.00  feet,  along
the southerly boundary of Lot 6B as described above,  approximately  105.25 feet
measured along the arc of said curve, to a point;

THENCE S. 84(degree) 10' 13" E., along the southerly boundary of Lot 6B as shown
on said plan, 15.85 feet to the place of beginning.

CONTAINING approximately 2,750 square feet of land.

                                      -14-
3150414.01

<PAGE>



                                                                   EXHIBIT 21


               SUBSIDIARIES OF PRECISION OPTICS CORPORATION, INC.


         1.       Wood's Precision Optics Corporation, Limited, organized under
                  the laws of Hong Kong.

         2.       Precise Medical, Inc., incorporated in Massachusetts.








                                       -1-
3153284.01

<PAGE>




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission